LOKIASV2_1571_ESMFold_hypothetical_protein	4hzu-assembly1.cif.gz_S	4hzu-assembly1.cif.gz_S Structure of a bacterial energy-coupling factor transporter	6.476E-07	1.000	312	24	196	206	2	162	164	174	0.840	0.982
LOKIASV2_1571_ESMFold_hypothetical_protein	5kc4-assembly1.cif.gz_A	5kc4-assembly1.cif.gz_A Structure of TmRibU, orthorhombic crystal form	8.996E-04	1.000	179	32	188	206	2	162	166	169	0.762	0.970
LOKIASV2_1571_ESMFold_hypothetical_protein	4dve-assembly1.cif.gz_A	4dve-assembly1.cif.gz_A Crystal structure at 2.1 A of the S-component for biotin from an ECF-type ABC transporter	1.457E-03	1.000	147	26	195	206	1	178	189	184	0.825	0.942
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly2.cif.gz_C	4z7f-assembly2.cif.gz_C Crystal structure of FolT bound with folic acid	2.634E-02	1.000	121	36	189	206	5	155	166	159	0.748	0.910
LOKIASV2_1571_ESMFold_hypothetical_protein	5d0y-assembly2.cif.gz_B	5d0y-assembly2.cif.gz_B Substrate bound S-component of folate ECF transporter	3.875E-02	1.000	113	35	185	206	3	148	155	156	0.733	0.942
LOKIASV2_1571_ESMFold_hypothetical_protein	4mhw-assembly1.cif.gz_A	4mhw-assembly1.cif.gz_A Crystal structure of ThiT with small molecule BAT-25	3.692E-02	0.999	99	35	205	206	5	171	177	183	0.830	0.944
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly1.cif.gz_A	4z7f-assembly1.cif.gz_A Crystal structure of FolT bound with folic acid	2.901E-02	0.999	97	33	189	206	2	159	163	166	0.762	0.969
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly1.cif.gz_B	4z7f-assembly1.cif.gz_B Crystal structure of FolT bound with folic acid	4.267E-02	0.998	95	36	184	206	6	151	168	157	0.723	0.869
LOKIASV2_1571_ESMFold_hypothetical_protein	4huq-assembly1.cif.gz_S	4huq-assembly1.cif.gz_S Crystal Structure of a transporter	4.478E-02	0.998	94	34	201	206	3	157	164	172	0.816	0.945
LOKIASV2_1571_ESMFold_hypothetical_protein	7nnt-assembly1.cif.gz_C	7nnt-assembly1.cif.gz_C Cryo-EM structure of the folate-specific ECF transporter complex in DDM micelles	8.385E-02	0.996	89	36	204	206	7	165	169	178	0.820	0.941
LOKIASV2_1571_ESMFold_hypothetical_protein	4tkr-assembly1.cif.gz_A	4tkr-assembly1.cif.gz_A Native-SAD phasing for ThiT from Listeria monocytogenes serovar.	6.913E-02	0.984	80	32	205	206	3	180	183	192	0.845	0.973
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly3.cif.gz_E	4z7f-assembly3.cif.gz_E Crystal structure of FolT bound with folic acid	1.516E+00	0.601	54	36	188	206	2	141	147	163	0.743	0.952
LOKIASV2_1571_ESMFold_hypothetical_protein	5mg3-assembly1.cif.gz_F	5mg3-assembly1.cif.gz_F EM fitted model of bacterial holo-translocon	1.752E+00	0.150	36	29	190	206	132	288	289	179	0.786	0.543
LOKIASV2_1571_ESMFold_hypothetical_protein	1h9u-assembly1.cif.gz_A	1h9u-assembly1.cif.gz_A The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268	5.244E-01	0.138	35	28	205	206	43	197	201	183	0.864	0.771
LOKIASV2_1571_ESMFold_hypothetical_protein	5kom-assembly1.cif.gz_A	5kom-assembly1.cif.gz_A The crystal structure of fluoride channel Fluc Ec2 F83I Mutant	1.590E+00	0.126	34	30	192	206	2	123	124	169	0.791	0.984
LOKIASV2_1571_ESMFold_hypothetical_protein	7qsd-assembly1.cif.gz_Y	7qsd-assembly1.cif.gz_Y Bovine complex I in the active state at 3.1 A	3.790E+00	0.126	34	67	182	206	18	125	139	126	0.563	0.777
LOKIASV2_1571_ESMFold_hypothetical_protein	6zkr-assembly1.cif.gz_V	6zkr-assembly1.cif.gz_V Native complex I, open3	3.612E+00	0.116	33	67	182	206	22	125	139	124	0.563	0.748
LOKIASV2_1571_ESMFold_hypothetical_protein	3zta-assembly1.cif.gz_A-2	3zta-assembly1.cif.gz_A-2 The bacterial stressosome: a modular system that has been adapted to control secondary messenger signaling	2.838E+00	0.116	33	71	201	206	5	128	139	142	0.636	0.892
LOKIASV2_1571_ESMFold_hypothetical_protein	5lq3-assembly2.cif.gz_D	5lq3-assembly2.cif.gz_D Structures and transport dynamics of the Campylobacter jejuni multidrug efflux pump CmeB	1.752E+00	0.116	33	29	193	206	340	492	1033	173	0.801	0.148
LOKIASV2_1571_ESMFold_hypothetical_protein	5h46-assembly1.cif.gz_A	5h46-assembly1.cif.gz_A Mycobacterium smegmatis Dps1 mutant - F47E	2.124E+00	0.106	32	26	185	206	1	148	149	184	0.777	0.993
LOKIASV2_1571_ESMFold_hypothetical_protein	4zva-assembly1.cif.gz_B	4zva-assembly1.cif.gz_B Crystal structure of globin domain of the E. coli DosC - form I (ferric)	3.279E+00	0.106	32	25	187	206	13	148	149	173	0.791	0.913
LOKIASV2_1571_ESMFold_hypothetical_protein	2rld-assembly1.cif.gz_E	2rld-assembly1.cif.gz_E CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM S23 RIBOSOMAL PROTEIN FAMILY (BT_0352) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION	8.606E+00	0.098	31	66	185	206	3	106	108	121	0.583	0.963
LOKIASV2_1571_ESMFold_hypothetical_protein	5hjp-assembly2.cif.gz_C	5hjp-assembly2.cif.gz_C Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	8.915E-01	0.098	31	30	206	206	53	199	216	177	0.859	0.681
LOKIASV2_1571_ESMFold_hypothetical_protein	2p4y-assembly1.cif.gz_B	2p4y-assembly1.cif.gz_B Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator	6.674E-01	0.098	31	26	206	206	71	227	227	184	0.879	0.692
LOKIASV2_1571_ESMFold_hypothetical_protein	8qee-assembly1.cif.gz_A	8qee-assembly1.cif.gz_A S. cerevisia Niemann-Pick type C protein NCR1 in Peptidisc at pH 7.5	4.824E+00	0.098	31	31	196	206	234	400	823	181	0.806	0.203
LOKIASV2_1571_ESMFold_hypothetical_protein	7rr8-assembly1.cif.gz_C	7rr8-assembly1.cif.gz_C Multidrug efflux pump subunit AcrB	2.024E+00	0.098	31	29	189	206	338	489	1027	176	0.782	0.148
LOKIASV2_1571_ESMFold_hypothetical_protein	5die-assembly1.cif.gz_B	5die-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol	2.455E+00	0.090	30	26	205	206	64	226	235	193	0.874	0.694
LOKIASV2_1571_ESMFold_hypothetical_protein	6b24-assembly1.cif.gz_A	6b24-assembly1.cif.gz_A Crystal structure of fluoride channel Fluc Ec2 F80Y Mutant	3.279E+00	0.082	29	30	192	206	2	123	124	170	0.791	0.984
LOKIASV2_1571_ESMFold_hypothetical_protein	6zkb-assembly1.cif.gz_V	6zkb-assembly1.cif.gz_V Membrane domain of closed complex I during turnover	5.575E+00	0.082	29	67	182	206	22	125	139	127	0.563	0.748
LOKIASV2_1571_ESMFold_hypothetical_protein	5dkb-assembly1.cif.gz_B	5dkb-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol	3.125E+00	0.082	29	26	200	206	65	218	232	190	0.850	0.664
LOKIASV2_1571_ESMFold_hypothetical_protein	1l2i-assembly2.cif.gz_A	1l2i-assembly2.cif.gz_A Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide	3.441E+00	0.082	29	30	200	206	76	219	233	176	0.830	0.618
LOKIASV2_1571_ESMFold_hypothetical_protein	1sj0-assembly1.cif.gz_A-2	1sj0-assembly1.cif.gz_A-2 Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D	1.516E+00	0.082	29	6	205	206	21	241	243	249	0.971	0.909
LOKIASV2_1571_ESMFold_hypothetical_protein	6qc4-assembly1.cif.gz_AK	6qc4-assembly1.cif.gz_AK Ovine respiratory supercomplex I+III2 open class 3	4.380E+00	0.076	28	67	182	206	23	126	140	128	0.563	0.743
LOKIASV2_1571_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_B	2q60-assembly1.cif.gz_B Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand	1.752E+00	0.076	28	27	195	206	40	190	198	174	0.820	0.763
LOKIASV2_1571_ESMFold_hypothetical_protein	5hjs-assembly1.cif.gz_A	5hjs-assembly1.cif.gz_A Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	2.024E+00	0.076	28	28	205	206	62	218	226	184	0.864	0.695
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs9-assembly1.cif.gz_B	7rs9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25	3.441E+00	0.076	28	30	200	206	59	213	226	183	0.830	0.686
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_C	7rry-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	3.125E+00	0.076	28	17	201	206	24	224	227	226	0.898	0.885
LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_C	5tnb-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	2.455E+00	0.076	28	19	187	206	25	207	229	209	0.820	0.799
LOKIASV2_1571_ESMFold_hypothetical_protein	8daf-assembly1.cif.gz_A	8daf-assembly1.cif.gz_A Human SF-1 LBD bound to synthetic agonist 6N-10CA and bacterial phospholipid	1.135E+00	0.076	28	25	185	206	59	204	230	172	0.782	0.635
LOKIASV2_1571_ESMFold_hypothetical_protein	1r5k-assembly2.cif.gz_C-2	1r5k-assembly2.cif.gz_C-2 Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638	4.380E+00	0.076	28	30	196	206	68	220	235	177	0.811	0.651
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly1.cif.gz_D	6s4n-assembly1.cif.gz_D LXRbeta ligand binding domain in comlpex with small molecule inhibitors	1.929E+00	0.076	28	30	206	206	67	226	235	188	0.859	0.681
LOKIASV2_1571_ESMFold_hypothetical_protein	1hg4-assembly2.cif.gz_F	1hg4-assembly2.cif.gz_F Ultraspiracle ligand binding domain from Drosophila melanogaster	1.838E+00	0.076	28	27	203	206	62	236	240	199	0.859	0.729
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly1.cif.gz_A	7rs2-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	2.455E+00	0.076	28	19	187	206	36	226	245	214	0.820	0.780
LOKIASV2_1571_ESMFold_hypothetical_protein	2q6s-assembly1.cif.gz_B	2q6s-assembly1.cif.gz_B 2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides	1.669E+00	0.076	28	26	201	206	96	252	253	179	0.854	0.621
LOKIASV2_1571_ESMFold_hypothetical_protein	8olt-assembly1.cif.gz_Y	8olt-assembly1.cif.gz_Y Mitochondrial complex I from Mus musculus in the active state bound with piericidin A	9.032E+00	0.069	27	67	186	206	21	125	142	129	0.583	0.739
LOKIASV2_1571_ESMFold_hypothetical_protein	4zvb-assembly2.cif.gz_D	4zvb-assembly2.cif.gz_D Crystal structure of globin domain of the E. coli DosC - form II (ferrous)	5.313E+00	0.069	27	29	185	206	2	146	149	174	0.762	0.973
LOKIASV2_1571_ESMFold_hypothetical_protein	6lit-assembly1.cif.gz_B	6lit-assembly1.cif.gz_B Estrogen-related receptor beta(ERR2) in complex with BPA	1.444E+00	0.069	27	29	201	206	11	196	197	198	0.840	0.944
LOKIASV2_1571_ESMFold_hypothetical_protein	6jnr-assembly1.cif.gz_A	6jnr-assembly1.cif.gz_A RXRa structure complexed with CU-6PMN and SRC1 peptide.	1.838E+00	0.069	27	30	201	206	57	198	214	173	0.835	0.664
LOKIASV2_1571_ESMFold_hypothetical_protein	1xdk-assembly1.cif.gz_A	1xdk-assembly1.cif.gz_A Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator	1.752E+00	0.069	27	27	206	206	52	207	217	188	0.874	0.719
LOKIASV2_1571_ESMFold_hypothetical_protein	3ipq-assembly1.cif.gz_A-2	3ipq-assembly1.cif.gz_A-2 X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha	2.838E+00	0.069	27	28	199	206	57	205	220	177	0.835	0.677
LOKIASV2_1571_ESMFold_hypothetical_protein	5avi-assembly1.cif.gz_C	5avi-assembly1.cif.gz_C Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4	1.444E+00	0.069	27	26	184	206	61	200	226	169	0.772	0.619
LOKIASV2_1571_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_B	2qgt-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound	5.062E+00	0.069	27	26	200	206	66	224	239	184	0.850	0.665
LOKIASV2_1571_ESMFold_hypothetical_protein	3r8a-assembly2.cif.gz_B	3r8a-assembly2.cif.gz_B X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity	2.024E+00	0.069	27	26	201	206	83	238	239	182	0.854	0.653
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs4-assembly1.cif.gz_A	7rs4-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	3.790E+00	0.069	27	19	196	206	31	230	244	225	0.864	0.820
LOKIASV2_1571_ESMFold_hypothetical_protein	2har-assembly1.cif.gz_A	2har-assembly1.cif.gz_A Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol	1.376E+00	0.069	27	25	206	206	41	240	252	222	0.883	0.794
LOKIASV2_1571_ESMFold_hypothetical_protein	1u77-assembly1.cif.gz_A	1u77-assembly1.cif.gz_A Crystal Structure of Ammonia Channel AmtB from E. Coli	3.279E+00	0.069	27	39	201	206	224	380	383	189	0.791	0.410
LOKIASV2_1571_ESMFold_hypothetical_protein	7v2c-assembly1.cif.gz_V	7v2c-assembly1.cif.gz_V Active state complex I from Q10 dataset	6.762E+00	0.063	26	72	182	206	4	126	140	132	0.539	0.879
LOKIASV2_1571_ESMFold_hypothetical_protein	2iu5-assembly1.cif.gz_B	2iu5-assembly1.cif.gz_B Dihydroxyacetone kinase operon activator DhaS	3.612E+00	0.063	26	32	180	206	2	174	177	182	0.723	0.977
LOKIASV2_1571_ESMFold_hypothetical_protein	2jsw-assembly1.cif.gz_A	2jsw-assembly1.cif.gz_A Solution Structure of the R13 Domain of Talin	6.762E+00	0.063	26	27	189	206	3	181	189	187	0.791	0.947
LOKIASV2_1571_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_A	5tbp-assembly1.cif.gz_A Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003	1.444E+00	0.063	26	28	203	206	31	196	198	194	0.854	0.838
LOKIASV2_1571_ESMFold_hypothetical_protein	7a78-assembly1.cif.gz_A-2	7a78-assembly1.cif.gz_A-2 Crystal structure of RXR beta LBD in complexes with palmitic acid and GRIP-1 peptide	2.124E+00	0.063	26	30	201	206	56	197	212	172	0.835	0.670
LOKIASV2_1571_ESMFold_hypothetical_protein	3os9-assembly1.cif.gz_C	3os9-assembly1.cif.gz_C Estrogen Receptor	4.824E+00	0.063	26	30	199	206	59	209	221	179	0.825	0.683
LOKIASV2_1571_ESMFold_hypothetical_protein	5kcf-assembly1.cif.gz_B	5kcf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-methoxybenzyl OBHS-N derivative	4.824E+00	0.063	26	17	201	206	26	224	227	229	0.898	0.877
LOKIASV2_1571_ESMFold_hypothetical_protein	7wmo-assembly1.cif.gz_A	7wmo-assembly1.cif.gz_A A novel chemical derivative(92) of THRB agonist	3.125E+00	0.063	26	30	200	206	74	221	229	176	0.830	0.646
LOKIASV2_1571_ESMFold_hypothetical_protein	4mg6-assembly1.cif.gz_A	4mg6-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate	3.790E+00	0.063	26	26	202	206	66	220	235	186	0.859	0.660
LOKIASV2_1571_ESMFold_hypothetical_protein	5m24-assembly1.cif.gz_A	5m24-assembly1.cif.gz_A RARg mutant-S371E	2.577E+00	0.063	26	34	187	206	79	211	236	166	0.748	0.564
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxm-assembly1.cif.gz_B	5dxm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol	5.851E+00	0.063	26	26	185	206	66	208	237	169	0.777	0.603
LOKIASV2_1571_ESMFold_hypothetical_protein	4pps-assembly1.cif.gz_A	4pps-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative	5.313E+00	0.063	26	26	200	206	65	223	238	188	0.850	0.668
LOKIASV2_1571_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_B	5kra-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	3.977E+00	0.063	26	26	187	206	66	211	240	173	0.786	0.608
LOKIASV2_1571_ESMFold_hypothetical_protein	1qku-assembly1.cif.gz_A	1qku-assembly1.cif.gz_A WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL	5.575E+00	0.063	26	30	200	206	46	233	250	202	0.830	0.752
LOKIASV2_1571_ESMFold_hypothetical_protein	3r8a-assembly1.cif.gz_A	3r8a-assembly1.cif.gz_A X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity	2.229E+00	0.063	26	26	206	206	90	247	251	184	0.879	0.629
LOKIASV2_1571_ESMFold_hypothetical_protein	8jr9-assembly1.cif.gz_R	8jr9-assembly1.cif.gz_R Small molecule agonist (PCO371) bound to human parathyroid hormone receptor type 1 (PTH1R)	7.096E+00	0.063	26	35	186	206	3	156	255	176	0.738	0.604
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgq-assembly1.cif.gz_A	6dgq-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10506	2.229E+00	0.063	26	26	199	206	91	240	257	177	0.845	0.584
LOKIASV2_1571_ESMFold_hypothetical_protein	7b5p-assembly1.cif.gz_C	7b5p-assembly1.cif.gz_C AcrB in cycloalkane amphipol	4.597E+00	0.063	26	29	189	206	337	488	1014	172	0.782	0.150
LOKIASV2_1571_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_C	3kfc-assembly2.cif.gz_C Complex Structure of LXR with an agonist	3.790E+00	0.057	25	29	189	206	53	183	186	168	0.782	0.704
LOKIASV2_1571_ESMFold_hypothetical_protein	5dvv-assembly1.cif.gz_A	5dvv-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4'-(phenylcarbonimidoyl)diphenol	3.612E+00	0.057	25	27	201	206	53	206	209	184	0.850	0.737
LOKIASV2_1571_ESMFold_hypothetical_protein	1mv9-assembly1.cif.gz_A	1mv9-assembly1.cif.gz_A Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide	2.577E+00	0.057	25	30	201	206	56	197	214	172	0.835	0.664
LOKIASV2_1571_ESMFold_hypothetical_protein	3uvv-assembly1.cif.gz_B	3uvv-assembly1.cif.gz_B Crystal Structure of the ligand binding domains of the thyroid receptor:retinoid X receptor complexed with 3,3',5 triiodo-L-thyronine and 9-cis retinoic acid	2.455E+00	0.057	25	30	206	206	62	208	218	177	0.859	0.674
LOKIASV2_1571_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_A	5tn9-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	2.455E+00	0.057	25	19	187	206	25	202	222	203	0.820	0.802
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6w-assembly1.cif.gz_B	2r6w-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain complexed to a SERM	3.279E+00	0.057	25	30	201	206	53	222	223	193	0.835	0.762
LOKIASV2_1571_ESMFold_hypothetical_protein	3ips-assembly1.cif.gz_A	3ips-assembly1.cif.gz_A X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha	2.704E+00	0.057	25	28	199	206	60	208	224	185	0.835	0.665
LOKIASV2_1571_ESMFold_hypothetical_protein	7tut-assembly1.cif.gz_6	7tut-assembly1.cif.gz_6 Structure of the rabbit 80S ribosome stalled on a 4-TMD Rhodopsin intermediate in complex with the multipass translocon	6.443E+00	0.057	25	28	187	206	32	218	224	200	0.777	0.835
LOKIASV2_1571_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_D	5jy3-assembly2.cif.gz_D CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927	1.838E+00	0.057	25	27	200	206	65	225	227	188	0.845	0.709
LOKIASV2_1571_ESMFold_hypothetical_protein	3plz-assembly1.cif.gz_A	3plz-assembly1.cif.gz_A Human LRH1 LBD bound to GR470	3.790E+00	0.057	25	30	200	206	72	218	231	174	0.830	0.636
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_C	7ujo-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	5.851E+00	0.057	25	30	205	206	72	224	233	183	0.854	0.657
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_B	6vjd-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	5.313E+00	0.057	25	30	205	206	57	227	235	195	0.854	0.728
LOKIASV2_1571_ESMFold_hypothetical_protein	5krf-assembly1.cif.gz_B	5krf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY derivative, 1a	4.824E+00	0.057	25	26	206	206	66	224	236	192	0.879	0.674
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly2.cif.gz_A	6s4n-assembly2.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	3.279E+00	0.057	25	26	199	206	72	221	236	190	0.845	0.636
LOKIASV2_1571_ESMFold_hypothetical_protein	5tmt-assembly1.cif.gz_A	5tmt-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((1,3-dihydro-2H-inden-2-ylidene)methylene)diphenol	4.380E+00	0.057	25	26	200	206	66	222	237	188	0.850	0.662
LOKIASV2_1571_ESMFold_hypothetical_protein	3x1i-assembly2.cif.gz_B	3x1i-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid	1.669E+00	0.057	25	26	205	206	81	233	237	191	0.874	0.646
LOKIASV2_1571_ESMFold_hypothetical_protein	4mg7-assembly1.cif.gz_A	4mg7-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with ferutinine	3.612E+00	0.057	25	18	202	206	24	223	239	228	0.898	0.837
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv1-assembly2.cif.gz_B	2vv1-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 4-HDHA	2.024E+00	0.057	25	27	200	206	82	238	239	180	0.845	0.657
LOKIASV2_1571_ESMFold_hypothetical_protein	1zdt-assembly3.cif.gz_B-2	1zdt-assembly3.cif.gz_B-2 The Crystal Structure of Human Steroidogenic Factor-1	2.229E+00	0.057	25	30	200	206	79	236	239	182	0.830	0.661
LOKIASV2_1571_ESMFold_hypothetical_protein	5krm-assembly1.cif.gz_B	5krm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol	6.140E+00	0.057	25	26	200	206	65	224	240	189	0.850	0.667
LOKIASV2_1571_ESMFold_hypothetical_protein	3fal-assembly1.cif.gz_D	3fal-assembly1.cif.gz_D humanRXR alpha & mouse LXR alpha complexed with Retenoic acid and GSK2186	3.125E+00	0.057	25	28	184	206	79	217	242	168	0.762	0.574
LOKIASV2_1571_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B	1gwq-assembly1.cif.gz_B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	6.443E+00	0.057	25	30	200	206	74	227	242	182	0.830	0.636
LOKIASV2_1571_ESMFold_hypothetical_protein	4xta-assembly3.cif.gz_B-2	4xta-assembly3.cif.gz_B-2 MECHANISMS OF PPARgamma ACTIVATION BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS	2.024E+00	0.057	25	26	201	206	80	228	243	179	0.854	0.613
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_A	7rs7-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	4.174E+00	0.057	25	30	187	206	69	217	244	176	0.767	0.611
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv3-assembly2.cif.gz_B	2vv3-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 4-oxoDHA	1.838E+00	0.057	25	26	200	206	88	244	246	182	0.850	0.638
LOKIASV2_1571_ESMFold_hypothetical_protein	8b8x-assembly2.cif.gz_B	8b8x-assembly2.cif.gz_B Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist	1.838E+00	0.057	25	27	204	206	99	250	252	183	0.864	0.603
LOKIASV2_1571_ESMFold_hypothetical_protein	6zly-assembly1.cif.gz_A	6zly-assembly1.cif.gz_A Crystal structure of the complex between PPARgamma LBD and the ligand NV1362 (7a)	2.577E+00	0.057	25	26	199	206	87	237	252	177	0.845	0.599
LOKIASV2_1571_ESMFold_hypothetical_protein	3x1h-assembly2.cif.gz_B	3x1h-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 5-oxo-tricosahexaenoic acid	2.340E+00	0.057	25	27	200	206	96	253	254	181	0.845	0.622
LOKIASV2_1571_ESMFold_hypothetical_protein	6kay-assembly1.cif.gz_A	6kay-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking	3.125E+00	0.057	25	26	199	206	90	240	258	182	0.845	0.585
LOKIASV2_1571_ESMFold_hypothetical_protein	3cwd-assembly2.cif.gz_B	3cwd-assembly2.cif.gz_B Molecular recognition of nitro-fatty acids by PPAR gamma	2.024E+00	0.057	25	26	204	206	93	244	260	182	0.869	0.585
LOKIASV2_1571_ESMFold_hypothetical_protein	3b9w-assembly1.cif.gz_A	3b9w-assembly1.cif.gz_A The 1.3 A resolution structure of Nitrosomonas europaea Rh50 and mechanistic implications for NH3 transport by Rhesus family proteins	4.380E+00	0.057	25	31	198	206	177	340	362	189	0.816	0.453
LOKIASV2_1571_ESMFold_hypothetical_protein	6ows-assembly1.cif.gz_C	6ows-assembly1.cif.gz_C Cryo-EM structure of an Acinetobacter baumannii multidrug efflux pump	3.612E+00	0.057	25	30	185	206	864	1004	1023	168	0.757	0.138
LOKIASV2_1571_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_A	7pdt-assembly1.cif.gz_A Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with BMS649 and a coactivator fragment	1.444E+00	0.051	24	29	206	206	5	201	209	214	0.864	0.943
LOKIASV2_1571_ESMFold_hypothetical_protein	7aos-assembly1.cif.gz_A	7aos-assembly1.cif.gz_A crystal structure of the RARalpha/RXRalpha ligand binding domain heterodimer in complex with a fragment of SRC1 coactivator	2.577E+00	0.051	24	27	183	206	57	195	216	166	0.762	0.644
LOKIASV2_1571_ESMFold_hypothetical_protein	1s9q-assembly1.cif.gz_B	1s9q-assembly1.cif.gz_B crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen	3.977E+00	0.051	24	31	206	206	39	216	216	197	0.854	0.824
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_A	5dxq-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol	8.201E+00	0.051	24	30	205	206	70	218	227	180	0.854	0.656
LOKIASV2_1571_ESMFold_hypothetical_protein	2yat-assembly1.cif.gz_A-2	2yat-assembly1.cif.gz_A-2 Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex	7.096E+00	0.051	24	30	187	206	70	199	227	161	0.767	0.573
LOKIASV2_1571_ESMFold_hypothetical_protein	7wqq-assembly1.cif.gz_A	7wqq-assembly1.cif.gz_A Retinoic acid receptor alpha mutant - N299H	5.062E+00	0.051	24	31	198	206	69	215	228	179	0.816	0.645
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_B	7ujy-assembly1.cif.gz_B Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	3.612E+00	0.051	24	30	206	206	70	231	231	192	0.859	0.701
LOKIASV2_1571_ESMFold_hypothetical_protein	4dk8-assembly1.cif.gz_A	4dk8-assembly1.cif.gz_A Crystal structure of LXR ligand binding domain in complex with partial agonist 5	3.977E+00	0.051	24	28	200	206	71	231	233	184	0.840	0.691
LOKIASV2_1571_ESMFold_hypothetical_protein	8daf-assembly2.cif.gz_B	8daf-assembly2.cif.gz_B Human SF-1 LBD bound to synthetic agonist 6N-10CA and bacterial phospholipid	2.455E+00	0.051	24	30	185	206	75	209	235	160	0.757	0.574
LOKIASV2_1571_ESMFold_hypothetical_protein	5dke-assembly1.cif.gz_B	5dke-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, methyl, cis-diaryl-ethylene compound 4,4'-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol	3.790E+00	0.051	24	4	185	206	19	203	235	215	0.883	0.787
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_A	6vjd-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	6.140E+00	0.051	24	17	205	206	24	224	235	229	0.917	0.855
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_C	7rs0-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	2.577E+00	0.051	24	19	201	206	26	235	236	232	0.888	0.890
LOKIASV2_1571_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_A	4dma-assembly1.cif.gz_A Crystal structure of ERa LBD in complex with RU100132	6.140E+00	0.051	24	18	205	206	26	226	238	224	0.913	0.845
LOKIASV2_1571_ESMFold_hypothetical_protein	4ple-assembly2.cif.gz_C	4ple-assembly2.cif.gz_C Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fragment of TIF-2	3.279E+00	0.051	24	30	196	206	81	224	239	170	0.811	0.603
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_D	7rs7-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	4.380E+00	0.051	24	17	187	206	26	214	239	211	0.830	0.791
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq6-assembly1.cif.gz_B	1pq6-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX	3.977E+00	0.051	24	26	202	206	76	240	241	196	0.859	0.685
LOKIASV2_1571_ESMFold_hypothetical_protein	1pk5-assembly1.cif.gz_A	1pk5-assembly1.cif.gz_A Crystal structure of the orphan nuclear receptor LRH-1	2.455E+00	0.051	24	21	201	206	38	239	242	230	0.879	0.835
LOKIASV2_1571_ESMFold_hypothetical_protein	1zh7-assembly2.cif.gz_B	1zh7-assembly2.cif.gz_B Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP	3.441E+00	0.051	24	30	203	206	81	241	243	187	0.845	0.663
LOKIASV2_1571_ESMFold_hypothetical_protein	4l98-assembly1.cif.gz_A	4l98-assembly1.cif.gz_A Crystal structure of the complex of F360L PPARgamma mutant with the ligand LT175	2.838E+00	0.051	24	30	204	206	79	227	244	179	0.850	0.611
LOKIASV2_1571_ESMFold_hypothetical_protein	2q5g-assembly1.cif.gz_A	2q5g-assembly1.cif.gz_A Ligand binding domain of PPAR delta receptor in complex with a partial agonist	3.125E+00	0.051	24	30	203	206	94	237	244	176	0.845	0.590
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_C	7rs4-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	5.062E+00	0.051	24	19	187	206	28	218	244	216	0.820	0.783
LOKIASV2_1571_ESMFold_hypothetical_protein	7bju-assembly1.cif.gz_A	7bju-assembly1.cif.gz_A Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI08346	1.590E+00	0.051	24	35	187	206	45	217	248	188	0.743	0.698
LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly3.cif.gz_C	7bjv-assembly3.cif.gz_C Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI09181	2.978E+00	0.051	24	29	187	206	83	221	252	162	0.772	0.552
LOKIASV2_1571_ESMFold_hypothetical_protein	6kxy-assembly1.cif.gz_A	6kxy-assembly1.cif.gz_A Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound B)	2.978E+00	0.051	24	26	204	206	86	237	253	183	0.869	0.601
LOKIASV2_1571_ESMFold_hypothetical_protein	6l96-assembly1.cif.gz_B	6l96-assembly1.cif.gz_B Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide	3.125E+00	0.051	24	31	199	206	94	237	254	171	0.820	0.567
LOKIASV2_1571_ESMFold_hypothetical_protein	2q6s-assembly1.cif.gz_A	2q6s-assembly1.cif.gz_A 2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides	2.978E+00	0.051	24	26	199	206	89	239	254	179	0.845	0.594
LOKIASV2_1571_ESMFold_hypothetical_protein	6dh9-assembly1.cif.gz_A	6dh9-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602	3.441E+00	0.051	24	26	199	206	92	242	259	177	0.845	0.583
LOKIASV2_1571_ESMFold_hypothetical_protein	6e5a-assembly1.cif.gz_A	6e5a-assembly1.cif.gz_A PPARg in complex with compound 4b	3.125E+00	0.051	24	26	196	206	92	243	259	174	0.830	0.587
LOKIASV2_1571_ESMFold_hypothetical_protein	4c9q-assembly2.cif.gz_B	4c9q-assembly2.cif.gz_B Structure of yeast mitochondrial ADP/ATP carrier isoform 3 inhibited by carboxyatractyloside (P21 crystal form)	7.447E+00	0.051	24	29	196	206	85	285	290	219	0.816	0.693
LOKIASV2_1571_ESMFold_hypothetical_protein	5ww9-assembly1.cif.gz_A	5ww9-assembly1.cif.gz_A Crystal structure of R73E mutant of the second DNA-Binding protein under starvation from Mycobacterium smegmatis	7.447E+00	0.045	23	3	183	206	1	156	161	196	0.879	0.969
LOKIASV2_1571_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_C	7cfo-assembly1.cif.gz_C Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	3.441E+00	0.045	23	27	201	206	43	193	206	181	0.850	0.733
LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly2.cif.gz_F	5kya-assembly2.cif.gz_F Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	4.174E+00	0.045	23	27	201	206	45	196	217	180	0.850	0.700
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq6-assembly3.cif.gz_D-2	1pq6-assembly3.cif.gz_D-2 HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX	4.174E+00	0.045	23	26	202	206	65	226	227	187	0.859	0.714
LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly1.cif.gz_A	5tnb-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	2.838E+00	0.045	23	19	193	206	25	214	227	215	0.850	0.837
LOKIASV2_1571_ESMFold_hypothetical_protein	6vgh-assembly1.cif.gz_B	6vgh-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant In Complex with Lasofoxifene	2.577E+00	0.045	23	22	200	206	24	226	227	226	0.869	0.894
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_A	7ujy-assembly1.cif.gz_A Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	5.313E+00	0.045	23	30	200	206	70	227	228	182	0.830	0.693
LOKIASV2_1571_ESMFold_hypothetical_protein	5tm2-assembly1.cif.gz_B	5tm2-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide	7.096E+00	0.045	23	24	200	206	61	220	231	192	0.859	0.693
LOKIASV2_1571_ESMFold_hypothetical_protein	6psj-assembly1.cif.gz_A	6psj-assembly1.cif.gz_A Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain	4.824E+00	0.045	23	30	206	206	64	232	232	193	0.859	0.728
LOKIASV2_1571_ESMFold_hypothetical_protein	4rak-assembly1.cif.gz_B	4rak-assembly1.cif.gz_B Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist	2.124E+00	0.045	23	26	181	206	2	208	232	214	0.757	0.892
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A	7ujf-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	6.443E+00	0.045	23	30	205	206	59	224	232	194	0.854	0.716
LOKIASV2_1571_ESMFold_hypothetical_protein	5duh-assembly1.cif.gz_B	5duh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide	6.443E+00	0.045	23	30	200	206	40	217	233	208	0.830	0.764
LOKIASV2_1571_ESMFold_hypothetical_protein	2pog-assembly1.cif.gz_A	2pog-assembly1.cif.gz_A Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold.	3.977E+00	0.045	23	29	206	206	66	233	233	194	0.864	0.721
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_A	7rry-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	4.824E+00	0.045	23	19	206	206	23	232	233	235	0.913	0.901
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly3.cif.gz_B	6s4n-assembly3.cif.gz_B LXRbeta ligand binding domain in comlpex with small molecule inhibitors	4.174E+00	0.045	23	30	206	206	72	224	233	182	0.859	0.657
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly2.cif.gz_D	7ujf-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	6.762E+00	0.045	23	19	205	206	25	224	233	229	0.908	0.858
LOKIASV2_1571_ESMFold_hypothetical_protein	3os8-assembly1.cif.gz_C	3os8-assembly1.cif.gz_C Estrogen Receptor	5.851E+00	0.045	23	30	205	206	60	221	234	189	0.854	0.692
LOKIASV2_1571_ESMFold_hypothetical_protein	5drm-assembly1.cif.gz_B	5drm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4'-thiene-2,5-diylbis(3-chlorophenol)	8.606E+00	0.045	23	26	197	206	61	220	235	188	0.835	0.681
LOKIASV2_1571_ESMFold_hypothetical_protein	4iw6-assembly1.cif.gz_B	4iw6-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b	9.478E+00	0.045	23	26	200	206	66	220	235	189	0.850	0.660
LOKIASV2_1571_ESMFold_hypothetical_protein	7n9o-assembly1.cif.gz_B	7n9o-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15)	3.977E+00	0.045	23	30	187	206	59	216	235	180	0.767	0.672
LOKIASV2_1571_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_B	4ivw-assembly3.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b	8.201E+00	0.045	23	26	200	206	67	223	238	187	0.850	0.660
LOKIASV2_1571_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_B	5t1z-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide	7.447E+00	0.045	23	26	200	206	64	223	238	188	0.850	0.672
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujm-assembly1.cif.gz_B	7ujm-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells	7.096E+00	0.045	23	30	205	206	56	225	238	195	0.854	0.714
LOKIASV2_1571_ESMFold_hypothetical_protein	4mgb-assembly1.cif.gz_A	4mgb-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with TCBPA	9.032E+00	0.045	23	30	200	206	76	225	240	175	0.830	0.625
LOKIASV2_1571_ESMFold_hypothetical_protein	1pcg-assembly1.cif.gz_B	1pcg-assembly1.cif.gz_B Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions	7.096E+00	0.045	23	30	206	206	77	234	243	187	0.859	0.650
LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly2.cif.gz_B	7bjv-assembly2.cif.gz_B Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI09181	3.790E+00	0.045	23	30	187	206	79	217	247	163	0.767	0.563
LOKIASV2_1571_ESMFold_hypothetical_protein	6md2-assembly1.cif.gz_A	6md2-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid	3.612E+00	0.045	23	26	198	206	90	243	255	176	0.840	0.604
LOKIASV2_1571_ESMFold_hypothetical_protein	6dh9-assembly2.cif.gz_B	6dh9-assembly2.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602	3.441E+00	0.045	23	26	201	206	96	252	256	181	0.854	0.613
LOKIASV2_1571_ESMFold_hypothetical_protein	6lxc-assembly1.cif.gz_A	6lxc-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delipidation and cross-seeding	3.612E+00	0.045	23	26	204	206	89	240	257	183	0.869	0.591
LOKIASV2_1571_ESMFold_hypothetical_protein	4xuh-assembly2.cif.gz_B	4xuh-assembly2.cif.gz_B PPARgamma ligand binding domain in complex with sulindac sulfide	3.977E+00	0.045	23	26	195	206	94	240	258	180	0.825	0.570
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgr-assembly1.cif.gz_A	6dgr-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10638	3.612E+00	0.045	23	26	206	206	94	251	261	185	0.879	0.605
LOKIASV2_1571_ESMFold_hypothetical_protein	3vjh-assembly1.cif.gz_A	3vjh-assembly1.cif.gz_A Human PPAR GAMMA ligand binding domain in complex with JKPL35	3.612E+00	0.045	23	26	206	206	94	251	261	184	0.879	0.605
LOKIASV2_1571_ESMFold_hypothetical_protein	2npd-assembly1.cif.gz_A	2npd-assembly1.cif.gz_A An unusual twin-His arrangement in the pore of ammonia channels is essential for substrate conductance	6.140E+00	0.045	23	39	204	206	211	363	368	188	0.806	0.416
LOKIASV2_1571_ESMFold_hypothetical_protein	8tid-assembly1.cif.gz_K	8tid-assembly1.cif.gz_K Combined linker domain of N-DRC and associated proteins Tetrahymena	4.380E+00	0.045	23	1	204	206	1	228	434	253	0.990	0.525
LOKIASV2_1571_ESMFold_hypothetical_protein	6npl-assembly1.cif.gz_A	6npl-assembly1.cif.gz_A Cryo-EM structure of NKCC1	4.380E+00	0.045	23	30	176	206	25	154	861	154	0.714	0.151
LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_B	6jno-assembly1.cif.gz_B RXRa structure complexed with CU-6PMN	2.577E+00	0.040	22	30	203	206	39	193	193	188	0.845	0.803
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly1.cif.gz_B	7ujw-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	5.062E+00	0.040	22	30	200	206	36	207	212	206	0.830	0.811
LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_B	5kya-assembly1.cif.gz_B Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	4.597E+00	0.040	22	27	201	206	45	196	216	180	0.850	0.704
LOKIASV2_1571_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_A	5e15-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	7.096E+00	0.040	22	30	198	206	35	201	218	196	0.820	0.766
LOKIASV2_1571_ESMFold_hypothetical_protein	5tn9-assembly2.cif.gz_C	5tn9-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	5.062E+00	0.040	22	19	187	206	24	203	224	208	0.820	0.804
LOKIASV2_1571_ESMFold_hypothetical_protein	5u2b-assembly2.cif.gz_D	5u2b-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide	4.824E+00	0.040	22	25	187	206	24	198	226	207	0.791	0.774
LOKIASV2_1571_ESMFold_hypothetical_protein	2e2r-assembly1.cif.gz_A	2e2r-assembly1.cif.gz_A Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol A	5.062E+00	0.040	22	30	196	206	37	211	227	190	0.811	0.771
LOKIASV2_1571_ESMFold_hypothetical_protein	6a5y-assembly1.cif.gz_A	6a5y-assembly1.cif.gz_A Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC143 and 9cRA and SRC1	5.851E+00	0.040	22	26	200	206	68	225	228	187	0.850	0.693
LOKIASV2_1571_ESMFold_hypothetical_protein	5krl-assembly1.cif.gz_B	5krl-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2-chloro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol	9.947E+00	0.040	22	27	205	206	62	219	228	193	0.869	0.693
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_B	7rs7-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	8.201E+00	0.040	22	17	200	206	26	216	228	225	0.893	0.838
LOKIASV2_1571_ESMFold_hypothetical_protein	5dwj-assembly1.cif.gz_B	5dwj-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-substituted Diaryl-imine analog 4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol	6.443E+00	0.040	22	26	202	206	65	213	229	185	0.859	0.651
LOKIASV2_1571_ESMFold_hypothetical_protein	1nde-assembly1.cif.gz_A	1nde-assembly1.cif.gz_A Estrogen Receptor beta with Selective Triazine Modulator	6.140E+00	0.040	22	30	203	206	70	229	231	186	0.845	0.693
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly1.cif.gz_B	7ujo-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	7.096E+00	0.040	22	18	205	206	20	222	234	236	0.913	0.868
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_C	7ujy-assembly2.cif.gz_C Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	4.380E+00	0.040	22	30	206	206	70	234	234	192	0.859	0.705
LOKIASV2_1571_ESMFold_hypothetical_protein	3ipu-assembly1.cif.gz_B	3ipu-assembly1.cif.gz_B X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha	3.612E+00	0.040	22	28	206	206	72	226	235	188	0.869	0.660
LOKIASV2_1571_ESMFold_hypothetical_protein	4iu7-assembly1.cif.gz_A	4iu7-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b	5.313E+00	0.040	22	26	201	206	67	232	235	199	0.854	0.706
LOKIASV2_1571_ESMFold_hypothetical_protein	1x7r-assembly1.cif.gz_A-2	1x7r-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN	4.824E+00	0.040	22	30	201	206	68	233	235	196	0.835	0.706
LOKIASV2_1571_ESMFold_hypothetical_protein	5krh-assembly1.cif.gz_B	5krh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16-benzylidene estrone	7.815E+00	0.040	22	20	200	206	26	222	237	213	0.879	0.831
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_B	1pq9-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	2.838E+00	0.040	22	26	188	206	2	214	238	228	0.791	0.895
LOKIASV2_1571_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_A	3osa-assembly1.cif.gz_A Estrogen Receptor	8.201E+00	0.040	22	30	187	206	67	217	239	175	0.767	0.632
LOKIASV2_1571_ESMFold_hypothetical_protein	5dlr-assembly1.cif.gz_B	5dlr-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound 4,4'-(2-phenylethene-1,1-diyl)diphenol	7.096E+00	0.040	22	17	185	206	26	208	240	214	0.820	0.762
LOKIASV2_1571_ESMFold_hypothetical_protein	1p8d-assembly3.cif.gz_A	1p8d-assembly3.cif.gz_A X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol	4.380E+00	0.040	22	26	184	206	74	213	240	164	0.772	0.583
LOKIASV2_1571_ESMFold_hypothetical_protein	4dos-assembly1.cif.gz_A	4dos-assembly1.cif.gz_A Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to DLPC and a Fragment of TIF-2	3.441E+00	0.040	22	30	201	206	83	241	242	181	0.835	0.657
LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_B	6jio-assembly2.cif.gz_B Human LXR-beta in complex with a ligand	5.313E+00	0.040	22	30	184	206	71	207	242	160	0.752	0.566
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs0-assembly1.cif.gz_A	7rs0-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	3.279E+00	0.040	22	19	200	206	26	229	242	233	0.883	0.843
LOKIASV2_1571_ESMFold_hypothetical_protein	5tms-assembly1.cif.gz_B	5tms-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC derivative, ethyl (E)-3-(4-(bicyclo[3.3.1]nonan-9-ylidene(4-hydroxyphenyl)methyl)phenyl)acrylate	8.606E+00	0.040	22	20	200	206	29	228	243	224	0.879	0.823
LOKIASV2_1571_ESMFold_hypothetical_protein	2xhs-assembly1.cif.gz_A	2xhs-assembly1.cif.gz_A Crystal structure of the ligand binding domain of Fushi tarazu factor 1 of Drosophila melanogaster.	5.062E+00	0.040	22	25	181	206	74	216	243	165	0.762	0.588
LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_D	6jio-assembly2.cif.gz_D Human LXR-beta in complex with a ligand	4.824E+00	0.040	22	26	184	206	73	212	247	164	0.772	0.567
LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly1.cif.gz_A	7bjv-assembly1.cif.gz_A Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI09181	4.174E+00	0.040	22	29	187	206	82	218	249	160	0.772	0.550
LOKIASV2_1571_ESMFold_hypothetical_protein	2j4a-assembly1.cif.gz_A	2j4a-assembly1.cif.gz_A Human Thyroid hormone receptor beta ligand binding domain in complex with KB131084	5.062E+00	0.040	22	15	205	206	36	240	250	232	0.927	0.820
LOKIASV2_1571_ESMFold_hypothetical_protein	2hwq-assembly1.cif.gz_B	2hwq-assembly1.cif.gz_B Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists	3.279E+00	0.040	22	27	204	206	95	246	253	182	0.864	0.601
LOKIASV2_1571_ESMFold_hypothetical_protein	5tto-assembly1.cif.gz_B-2	5tto-assembly1.cif.gz_B-2 X-ray crystal structure of PPARgamma in complex with SR1643	4.597E+00	0.040	22	26	198	206	92	241	258	176	0.840	0.581
LOKIASV2_1571_ESMFold_hypothetical_protein	2b50-assembly1.cif.gz_A	2b50-assembly1.cif.gz_A Human Nuclear Receptor-Ligand Complex 2	4.597E+00	0.040	22	26	199	206	94	243	261	179	0.845	0.575
LOKIASV2_1571_ESMFold_hypothetical_protein	3an4-assembly2.cif.gz_A	3an4-assembly2.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R	3.977E+00	0.040	22	29	206	206	73	252	262	209	0.864	0.687
LOKIASV2_1571_ESMFold_hypothetical_protein	3an3-assembly2.cif.gz_A	3an3-assembly2.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S	4.597E+00	0.040	22	26	199	206	96	246	263	177	0.845	0.574
LOKIASV2_1571_ESMFold_hypothetical_protein	7c6q-assembly1.cif.gz_A	7c6q-assembly1.cif.gz_A Novel natural PPARalpha agonist with a unique binding mode	3.977E+00	0.040	22	26	204	206	96	247	264	183	0.869	0.576
LOKIASV2_1571_ESMFold_hypothetical_protein	6lx4-assembly2.cif.gz_B	6lx4-assembly2.cif.gz_B X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization	4.174E+00	0.040	22	26	204	206	100	251	268	183	0.869	0.567
LOKIASV2_1571_ESMFold_hypothetical_protein	3cs8-assembly1.cif.gz_A	3cs8-assembly1.cif.gz_A Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a	4.824E+00	0.040	22	26	187	206	102	241	269	165	0.786	0.520
LOKIASV2_1571_ESMFold_hypothetical_protein	6ivp-assembly1.cif.gz_A	6ivp-assembly1.cif.gz_A Crystal structure of a membrane protein P262A	6.762E+00	0.040	22	29	200	206	34	197	273	186	0.835	0.601
LOKIASV2_1571_ESMFold_hypothetical_protein	3adw-assembly1.cif.gz_A	3adw-assembly1.cif.gz_A Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid	5.313E+00	0.040	22	26	199	206	107	257	274	177	0.845	0.551
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbb-assembly2.cif.gz_B	6sbb-assembly2.cif.gz_B Structure of type II terpene cyclase MstE from Scytonema (apo)	3.279E+00	0.040	22	26	183	206	1	120	340	167	0.767	0.353
LOKIASV2_1571_ESMFold_hypothetical_protein	4xnv-assembly1.cif.gz_A	4xnv-assembly1.cif.gz_A The human P2Y1 receptor in complex with BPTU	3.279E+00	0.040	22	23	187	206	5	203	340	215	0.801	0.585
LOKIASV2_1571_ESMFold_hypothetical_protein	3b9y-assembly1.cif.gz_A	3b9y-assembly1.cif.gz_A Crystal structure of the Nitrosomonas europaea Rh protein	6.762E+00	0.040	22	31	198	206	178	341	388	189	0.816	0.423
LOKIASV2_1571_ESMFold_hypothetical_protein	5iwk-assembly1.cif.gz_A	5iwk-assembly1.cif.gz_A Structure of Transient Receptor Potential (TRP) channel TRPV6	4.380E+00	0.040	22	28	200	206	300	532	594	245	0.840	0.392
LOKIASV2_1571_ESMFold_hypothetical_protein	4uiq-assembly2.cif.gz_A	4uiq-assembly2.cif.gz_A Isolated globin domain of the Bordetella pertussis globin-coupled sensor with a heme at the dimer interface	9.032E+00	0.034	21	27	186	206	16	153	154	164	0.777	0.896
LOKIASV2_1571_ESMFold_hypothetical_protein	8h17-assembly1.cif.gz_A	8h17-assembly1.cif.gz_A Crystal structure of the Globin domain of Thermosynechococcus elongatus BP-1	5.851E+00	0.034	21	30	189	206	2	156	157	181	0.777	0.987
LOKIASV2_1571_ESMFold_hypothetical_protein	4m32-assembly1.cif.gz_A	4m32-assembly1.cif.gz_A Crystal structure of gated-pore mutant D138N of second DNA-Binding protein under starvation from Mycobacterium smegmatis	8.201E+00	0.034	21	6	183	206	3	155	160	194	0.864	0.956
LOKIASV2_1571_ESMFold_hypothetical_protein	4m32-assembly1.cif.gz_C	4m32-assembly1.cif.gz_C Crystal structure of gated-pore mutant D138N of second DNA-Binding protein under starvation from Mycobacterium smegmatis	8.606E+00	0.034	21	6	183	206	3	155	160	194	0.864	0.956
LOKIASV2_1571_ESMFold_hypothetical_protein	4m35-assembly1.cif.gz_A	4m35-assembly1.cif.gz_A Crystal structure of gated-pore mutant H126/141D of second DNA-Binding protein under starvation from Mycobacterium smegmatis	5.062E+00	0.034	21	3	196	206	1	158	161	208	0.942	0.981
LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_C	6jno-assembly1.cif.gz_C RXRa structure complexed with CU-6PMN	3.279E+00	0.034	21	29	201	206	3	188	200	201	0.840	0.930
LOKIASV2_1571_ESMFold_hypothetical_protein	6suo-assembly1.cif.gz_B	6suo-assembly1.cif.gz_B ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6)	4.174E+00	0.034	21	25	200	206	18	198	202	204	0.854	0.896
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly1.cif.gz_C	7ujw-assembly1.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	5.575E+00	0.034	21	26	198	206	24	207	208	219	0.840	0.885
LOKIASV2_1571_ESMFold_hypothetical_protein	5ji0-assembly2.cif.gz_A	5ji0-assembly2.cif.gz_A PPARgamma-RXRalpha(S427F) heterodimer in complex with SRC-1, rosiglitazone, and 9-cis-retanoic acid	5.062E+00	0.034	21	30	201	206	66	207	216	173	0.835	0.657
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_D-3	7rrx-assembly2.cif.gz_D-3 Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19	7.447E+00	0.034	21	30	201	206	32	214	216	212	0.835	0.847
LOKIASV2_1571_ESMFold_hypothetical_protein	6pit-assembly1.cif.gz_A	6pit-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with SRC2 Stapled Peptide 41A and Estradiol	2.838E+00	0.034	21	31	201	206	30	218	220	206	0.830	0.859
LOKIASV2_1571_ESMFold_hypothetical_protein	1s9q-assembly1.cif.gz_A	1s9q-assembly1.cif.gz_A crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen	4.380E+00	0.034	21	30	203	206	37	213	224	199	0.845	0.790
LOKIASV2_1571_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_B	6zoq-assembly1.cif.gz_B Oestrogen receptor ligand binding domain in complex with compound 16	3.441E+00	0.034	21	23	201	206	25	223	225	223	0.869	0.884
LOKIASV2_1571_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_A	2iok-assembly1.cif.gz_A Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	7.096E+00	0.034	21	26	205	206	28	219	227	220	0.874	0.846
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly1.cif.gz_B	7rs8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	5.313E+00	0.034	21	18	201	206	26	226	227	223	0.893	0.885
LOKIASV2_1571_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_B	2iok-assembly1.cif.gz_B Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	5.851E+00	0.034	21	18	198	206	23	226	228	232	0.879	0.895
LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly2.cif.gz_C	5w9c-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen	9.478E+00	0.034	21	30	205	206	54	214	228	196	0.854	0.706
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6w-assembly1.cif.gz_A	2r6w-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain complexed to a SERM	6.762E+00	0.034	21	27	204	206	25	228	229	234	0.864	0.891
LOKIASV2_1571_ESMFold_hypothetical_protein	5jmm-assembly1.cif.gz_A	5jmm-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with biochanin A	9.478E+00	0.034	21	17	200	206	25	216	231	223	0.893	0.831
LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly1.cif.gz_A	5w9c-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen	7.815E+00	0.034	21	30	205	206	70	219	233	185	0.854	0.644
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_D	6vjd-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	7.096E+00	0.034	21	30	205	206	58	223	235	195	0.854	0.706
LOKIASV2_1571_ESMFold_hypothetical_protein	8ev1-assembly1.cif.gz_A	8ev1-assembly1.cif.gz_A Dual Modulators	4.380E+00	0.034	21	30	201	206	41	235	237	223	0.835	0.823
LOKIASV2_1571_ESMFold_hypothetical_protein	7n9o-assembly2.cif.gz_D	7n9o-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15)	3.790E+00	0.034	21	30	205	206	58	225	237	201	0.854	0.709
LOKIASV2_1571_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_A	2qgt-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound	8.606E+00	0.034	21	26	201	206	66	234	237	200	0.854	0.713
LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly2.cif.gz_C-2	6vpf-assembly2.cif.gz_C-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene	7.096E+00	0.034	21	18	205	206	25	224	237	232	0.913	0.844
LOKIASV2_1571_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_C	8duk-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	4.597E+00	0.034	21	19	206	206	23	238	238	238	0.913	0.908
LOKIASV2_1571_ESMFold_hypothetical_protein	4mgc-assembly1.cif.gz_A	4mgc-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with benzophenone-2	9.032E+00	0.034	21	20	200	206	25	222	238	221	0.879	0.832
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4t-assembly1.cif.gz_A	6s4t-assembly1.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	4.174E+00	0.034	21	27	205	206	3	231	238	240	0.869	0.962
LOKIASV2_1571_ESMFold_hypothetical_protein	5tmv-assembly1.cif.gz_B	5tmv-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-iodophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	8.606E+00	0.034	21	26	205	206	67	230	239	196	0.874	0.686
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_C	6vjd-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	6.443E+00	0.034	21	22	205	206	24	228	239	234	0.893	0.858
LOKIASV2_1571_ESMFold_hypothetical_protein	1yin-assembly1.cif.gz_A-2	1yin-assembly1.cif.gz_A-2 Human estrogen receptor alpha ligand-binding domain in complex with compound 3F	5.851E+00	0.034	21	13	205	206	24	239	241	242	0.937	0.896
LOKIASV2_1571_ESMFold_hypothetical_protein	2acl-assembly1.cif.gz_B	2acl-assembly1.cif.gz_B Liver X-Receptor alpha Ligand Binding Domain with SB313987	4.597E+00	0.034	21	27	204	206	4	229	242	236	0.864	0.934
LOKIASV2_1571_ESMFold_hypothetical_protein	5kyj-assembly2.cif.gz_E	5kyj-assembly2.cif.gz_E Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	3.977E+00	0.034	21	24	193	206	1	224	245	229	0.825	0.914
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv4-assembly2.cif.gz_B	2vv4-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 6-oxoOTE	4.597E+00	0.034	21	27	200	206	89	245	247	181	0.845	0.636
LOKIASV2_1571_ESMFold_hypothetical_protein	6t9c-assembly1.cif.gz_B	6t9c-assembly1.cif.gz_B Crystal structure of the complex between PPARgamma LBD and the ligand NV1346 (3a)	5.575E+00	0.034	21	31	198	206	89	233	248	173	0.816	0.585
LOKIASV2_1571_ESMFold_hypothetical_protein	5u5l-assembly1.cif.gz_B-2	5u5l-assembly1.cif.gz_B-2 X-ray Crystal Structure of the PPARgamma Ligand Binding Domain in Complex with Rivoglitazone	5.062E+00	0.034	21	26	200	206	92	250	254	181	0.850	0.626
LOKIASV2_1571_ESMFold_hypothetical_protein	6dha-assembly1.cif.gz_A	6dha-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Hydroxy Pioglitazone (M-IV)	5.313E+00	0.034	21	26	198	206	88	241	255	176	0.840	0.604
LOKIASV2_1571_ESMFold_hypothetical_protein	2rew-assembly1.cif.gz_A	2rew-assembly1.cif.gz_A Crystal Structure of PPARalpha ligand binding domain with BMS-631707	5.062E+00	0.034	21	25	204	206	87	239	255	184	0.874	0.600
LOKIASV2_1571_ESMFold_hypothetical_protein	6f2l-assembly1.cif.gz_A	6f2l-assembly1.cif.gz_A Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days.	5.313E+00	0.034	21	26	199	206	94	244	259	178	0.845	0.583
LOKIASV2_1571_ESMFold_hypothetical_protein	2xyj-assembly2.cif.gz_B	2xyj-assembly2.cif.gz_B Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy	4.174E+00	0.034	21	34	184	206	98	228	259	156	0.733	0.506
LOKIASV2_1571_ESMFold_hypothetical_protein	3et1-assembly1.cif.gz_A	3et1-assembly1.cif.gz_A Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid	6.762E+00	0.034	21	29	204	206	101	246	263	182	0.854	0.555
LOKIASV2_1571_ESMFold_hypothetical_protein	2xyw-assembly2.cif.gz_B	2xyw-assembly2.cif.gz_B Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy	5.313E+00	0.034	21	29	206	206	102	253	263	180	0.864	0.578
LOKIASV2_1571_ESMFold_hypothetical_protein	1k7l-assembly4.cif.gz_G	1k7l-assembly4.cif.gz_G The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide.	5.062E+00	0.034	21	26	204	206	99	250	267	183	0.869	0.569
LOKIASV2_1571_ESMFold_hypothetical_protein	5dv8-assembly1.cif.gz_A	5dv8-assembly1.cif.gz_A Human PPARgamma ligand binding dmain complexed with SB1451 in a covalent bonded form	6.762E+00	0.034	21	26	187	206	101	240	269	165	0.786	0.520
LOKIASV2_1571_ESMFold_hypothetical_protein	5vyd-assembly2.cif.gz_B	5vyd-assembly2.cif.gz_B Crystal structure of phosphodiesterase domain of RhoPDE fusion protein from the Choanoflagellate Salpingoeca rosetta	2.229E+00	0.034	21	30	194	206	175	316	317	172	0.801	0.448
LOKIASV2_1571_ESMFold_hypothetical_protein	7prv-assembly1.cif.gz_A	7prv-assembly1.cif.gz_A The glucocorticoid receptor in complex with fluticasone furoate, a PGC1a coactivator fragment and sgk 23bp	6.140E+00	0.034	21	20	205	206	92	297	321	223	0.903	0.642
LOKIASV2_1571_ESMFold_hypothetical_protein	4k0j-assembly2.cif.gz_E	4k0j-assembly2.cif.gz_E X-ray crystal structure of a heavy metal efflux pump, crystal form I	9.478E+00	0.034	21	31	201	206	804	952	954	177	0.830	0.156
LOKIASV2_1571_ESMFold_hypothetical_protein	4a25-assembly1.cif.gz_B	4a25-assembly1.cif.gz_B X-ray structure Dps from Kineococcus radiotolerans in complex with Mn (II) ions.	9.032E+00	0.029	20	26	183	206	21	161	169	183	0.767	0.834
LOKIASV2_1571_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_A	7cfo-assembly1.cif.gz_A Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	3.612E+00	0.029	20	27	203	206	30	193	193	195	0.859	0.850
LOKIASV2_1571_ESMFold_hypothetical_protein	8t06-assembly1.cif.gz_B	8t06-assembly1.cif.gz_B Structure of mouse Myomaker mutant-R107A bound to Fab18G7	8.201E+00	0.029	20	45	180	206	2	127	199	148	0.660	0.633
LOKIASV2_1571_ESMFold_hypothetical_protein	8apy-assembly1.cif.gz_A	8apy-assembly1.cif.gz_A Crystal structure of the H12A variant of the KDEL receptor bound to sybody	5.575E+00	0.029	20	27	190	206	1	203	204	214	0.796	0.995
LOKIASV2_1571_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_B	8du9-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	7.096E+00	0.029	20	30	187	206	35	200	215	199	0.767	0.772
LOKIASV2_1571_ESMFold_hypothetical_protein	1osh-assembly1.cif.gz_A	1osh-assembly1.cif.gz_A A Chemical, Genetic, and Structural Analysis of the nuclear bile acid receptor FXR	5.062E+00	0.029	20	26	196	206	24	202	216	212	0.830	0.829
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrz-assembly2.cif.gz_D	7rrz-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	7.096E+00	0.029	20	30	187	206	60	201	218	171	0.767	0.651
LOKIASV2_1571_ESMFold_hypothetical_protein	7y8f-assembly2.cif.gz_B	7y8f-assembly2.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with an Inhibitor 30o and GRIP Peptide	7.815E+00	0.029	20	27	187	206	30	210	220	206	0.782	0.823
LOKIASV2_1571_ESMFold_hypothetical_protein	5yxj-assembly2.cif.gz_B	5yxj-assembly2.cif.gz_B FXR ligand binding domain	6.443E+00	0.029	20	22	202	206	32	220	220	221	0.879	0.859
LOKIASV2_1571_ESMFold_hypothetical_protein	6s5k-assembly1.cif.gz_A	6s5k-assembly1.cif.gz_A LXRbeta ligand binding domain in complex with small molecule inhibitors	9.032E+00	0.029	20	27	196	206	59	209	223	175	0.825	0.677
LOKIASV2_1571_ESMFold_hypothetical_protein	6a5z-assembly2.cif.gz_H	6a5z-assembly2.cif.gz_H Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1	5.062E+00	0.029	20	30	180	206	48	197	224	177	0.733	0.670
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_D	7rs1-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	5.313E+00	0.029	20	30	205	206	58	214	227	192	0.854	0.692
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_C	6dfn-assembly2.cif.gz_C Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	5.313E+00	0.029	20	30	205	206	34	215	228	216	0.854	0.798
LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly2.cif.gz_B	7msa-assembly2.cif.gz_B GDC-9545 in complex with estrogen receptor alpha	7.096E+00	0.029	20	23	187	206	25	211	228	211	0.801	0.820
LOKIASV2_1571_ESMFold_hypothetical_protein	5tlg-assembly1.cif.gz_A	5tlg-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4''-dihydroxy-3'-((hydroxyiminio)methyl)-[1,1':2',1''-terphenyl]-4'-olate	9.478E+00	0.029	20	31	200	206	37	214	229	195	0.825	0.777
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxp-assembly1.cif.gz_B	5dxp-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol	8.606E+00	0.029	20	35	200	206	7	215	230	219	0.806	0.909
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_C	7rs1-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	6.443E+00	0.029	20	17	201	206	25	232	233	234	0.898	0.893
LOKIASV2_1571_ESMFold_hypothetical_protein	6zos-assembly1.cif.gz_B	6zos-assembly1.cif.gz_B Oestrogen receptor ligand binding domain in complex with compound 18	9.478E+00	0.029	20	30	187	206	63	212	233	172	0.767	0.644
LOKIASV2_1571_ESMFold_hypothetical_protein	5dz0-assembly1.cif.gz_B	5dz0-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol	9.478E+00	0.029	20	20	200	206	26	218	234	205	0.879	0.825
LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly1.cif.gz_D	7msa-assembly1.cif.gz_D GDC-9545 in complex with estrogen receptor alpha	5.062E+00	0.029	20	19	193	206	25	221	234	224	0.850	0.842
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_C	7rrx-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19	7.096E+00	0.029	20	19	205	206	24	221	234	238	0.908	0.846
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4u-assembly3.cif.gz_C	6s4u-assembly3.cif.gz_C LXRbeta ligand binding domain in comlpex with small molecule inhibitors	5.851E+00	0.029	20	30	205	206	73	227	234	183	0.854	0.662
LOKIASV2_1571_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_B	4dma-assembly1.cif.gz_B Crystal structure of ERa LBD in complex with RU100132	9.947E+00	0.029	20	26	206	206	68	224	235	192	0.879	0.668
LOKIASV2_1571_ESMFold_hypothetical_protein	7tt8-assembly1.cif.gz_A	7tt8-assembly1.cif.gz_A Human LRH-1 LBD bound to agonist 6N-10CA and fragment of Tif2 coactivator	7.096E+00	0.029	20	30	186	206	76	208	235	158	0.762	0.566
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_B	7ujf-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	7.815E+00	0.029	20	30	206	206	56	235	235	204	0.859	0.766
LOKIASV2_1571_ESMFold_hypothetical_protein	1yok-assembly1.cif.gz_A	1yok-assembly1.cif.gz_A crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol	5.062E+00	0.029	20	20	196	206	31	221	236	219	0.859	0.809
LOKIASV2_1571_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_F	5kra-assembly2.cif.gz_F Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	7.447E+00	0.029	20	26	201	206	66	233	237	200	0.854	0.709
LOKIASV2_1571_ESMFold_hypothetical_protein	5krc-assembly1.cif.gz_B	5krc-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone	9.478E+00	0.029	20	20	200	206	26	221	238	223	0.879	0.824
LOKIASV2_1571_ESMFold_hypothetical_protein	1zky-assembly1.cif.gz_A	1zky-assembly1.cif.gz_A Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide	7.096E+00	0.029	20	26	204	206	67	238	239	204	0.869	0.720
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9m-assembly1.cif.gz_A	6k9m-assembly1.cif.gz_A Human LXR-beta in complex with an agonist	5.575E+00	0.029	20	30	185	206	71	204	242	161	0.757	0.554
LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly1.cif.gz_B	6vpf-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene	8.201E+00	0.029	20	13	187	206	25	218	243	224	0.850	0.798
LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_A	5kya-assembly1.cif.gz_A Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	3.977E+00	0.029	20	24	201	206	1	235	244	244	0.864	0.963
LOKIASV2_1571_ESMFold_hypothetical_protein	4tuz-assembly1.cif.gz_B	4tuz-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol	7.096E+00	0.029	20	30	196	206	76	227	244	178	0.811	0.623
LOKIASV2_1571_ESMFold_hypothetical_protein	3t03-assembly2.cif.gz_B	3t03-assembly2.cif.gz_B Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16	6.443E+00	0.029	20	26	206	206	85	238	249	184	0.879	0.618
LOKIASV2_1571_ESMFold_hypothetical_protein	1nav-assembly1.cif.gz_A	1nav-assembly1.cif.gz_A Thyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1	3.790E+00	0.029	20	30	205	206	60	241	253	206	0.854	0.719
LOKIASV2_1571_ESMFold_hypothetical_protein	3d5f-assembly3.cif.gz_B	3d5f-assembly3.cif.gz_B Crystal Structure of PPAR-delta complex	6.762E+00	0.029	20	28	202	206	88	238	254	179	0.850	0.594
LOKIASV2_1571_ESMFold_hypothetical_protein	3g8i-assembly1.cif.gz_A	3g8i-assembly1.cif.gz_A Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes	8.606E+00	0.029	20	27	198	206	87	235	254	181	0.835	0.587
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv4-assembly1.cif.gz_A	2vv4-assembly1.cif.gz_A hPPARgamma Ligand binding domain in complex with 6-oxoOTE	7.447E+00	0.029	20	26	199	206	88	238	254	177	0.845	0.594
LOKIASV2_1571_ESMFold_hypothetical_protein	7efq-assembly1.cif.gz_B	7efq-assembly1.cif.gz_B Crystal structure of hPPARgamma ligand binding domain complexed with rosiglitazone-based fluorescence probe	5.851E+00	0.029	20	26	205	206	95	250	255	183	0.874	0.612
LOKIASV2_1571_ESMFold_hypothetical_protein	6f2l-assembly1.cif.gz_B	6f2l-assembly1.cif.gz_B Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days.	6.762E+00	0.029	20	26	206	206	96	255	255	185	0.879	0.627
LOKIASV2_1571_ESMFold_hypothetical_protein	3fur-assembly1.cif.gz_A	3fur-assembly1.cif.gz_A Crystal Structure of PPARg in complex with INT131	5.851E+00	0.029	20	29	204	206	91	239	256	189	0.854	0.582
LOKIASV2_1571_ESMFold_hypothetical_protein	2q61-assembly1.cif.gz_A	2q61-assembly1.cif.gz_A Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145	6.140E+00	0.029	20	26	204	206	88	239	256	182	0.869	0.594
LOKIASV2_1571_ESMFold_hypothetical_protein	2xkw-assembly2.cif.gz_B	2xkw-assembly2.cif.gz_B LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE	5.851E+00	0.029	20	26	200	206	96	254	256	182	0.850	0.621
LOKIASV2_1571_ESMFold_hypothetical_protein	6c1i-assembly1.cif.gz_B-2	6c1i-assembly1.cif.gz_B-2 Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907	5.851E+00	0.029	20	26	200	206	96	255	258	183	0.850	0.620
LOKIASV2_1571_ESMFold_hypothetical_protein	3v9t-assembly1.cif.gz_A	3v9t-assembly1.cif.gz_A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator	5.062E+00	0.029	20	27	204	206	94	244	258	188	0.864	0.585
LOKIASV2_1571_ESMFold_hypothetical_protein	5y7x-assembly1.cif.gz_A	5y7x-assembly1.cif.gz_A Human Peroxisome proliferator-activated receptor (PPAR) delta in complexed with a potent and selective agonist	8.201E+00	0.029	20	31	187	206	99	231	258	159	0.762	0.516
LOKIASV2_1571_ESMFold_hypothetical_protein	2q61-assembly1.cif.gz_B	2q61-assembly1.cif.gz_B Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145	4.174E+00	0.029	20	27	204	206	95	245	259	182	0.864	0.583
LOKIASV2_1571_ESMFold_hypothetical_protein	2zk0-assembly2.cif.gz_B-2	2zk0-assembly2.cif.gz_B-2 Human peroxisome proliferator-activated receptor gamma ligand binding domain	6.140E+00	0.029	20	27	203	206	97	251	259	182	0.859	0.598
LOKIASV2_1571_ESMFold_hypothetical_protein	7qb1-assembly1.cif.gz_BBB	7qb1-assembly1.cif.gz_BBB PPARg in complex with inhibitor	7.096E+00	0.029	20	27	199	206	97	246	260	176	0.840	0.577
LOKIASV2_1571_ESMFold_hypothetical_protein	5y2t-assembly1.cif.gz_B-2	5y2t-assembly1.cif.gz_B-2 Structure of PPARgamma ligand binding domain - lobeglitazone complex	6.762E+00	0.029	20	26	204	206	97	248	263	182	0.869	0.578
LOKIASV2_1571_ESMFold_hypothetical_protein	6z12-assembly3.cif.gz_C	6z12-assembly3.cif.gz_C Salmonella AcrB solubilised in the SMA copolymer	8.606E+00	0.029	20	29	206	206	337	497	1010	185	0.864	0.159
LOKIASV2_1571_ESMFold_hypothetical_protein	5vot-assembly1.cif.gz_F	5vot-assembly1.cif.gz_F Structure of AMPA receptor-TARP complex	7.096E+00	0.024	19	31	199	206	4	172	175	195	0.820	0.966
LOKIASV2_1571_ESMFold_hypothetical_protein	5t97-assembly1.cif.gz_B	5t97-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid	9.947E+00	0.024	19	31	187	206	25	185	191	177	0.762	0.843
LOKIASV2_1571_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_A	2q60-assembly1.cif.gz_A Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand	7.096E+00	0.024	19	28	189	206	42	186	198	168	0.786	0.732
LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_D	6jno-assembly1.cif.gz_D RXRa structure complexed with CU-6PMN	5.313E+00	0.024	19	29	201	206	3	191	203	204	0.840	0.931
LOKIASV2_1571_ESMFold_hypothetical_protein	5yxl-assembly2.cif.gz_C	5yxl-assembly2.cif.gz_C A ligand M binding to FXR	7.447E+00	0.024	19	30	180	206	38	190	210	173	0.733	0.729
LOKIASV2_1571_ESMFold_hypothetical_protein	5hjp-assembly1.cif.gz_A	5hjp-assembly1.cif.gz_A Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	3.790E+00	0.024	19	29	206	206	4	198	215	213	0.864	0.907
LOKIASV2_1571_ESMFold_hypothetical_protein	1s9p-assembly1.cif.gz_A	1s9p-assembly1.cif.gz_A crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol	5.313E+00	0.024	19	27	201	206	22	210	215	209	0.850	0.879
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_B	6dfn-assembly1.cif.gz_B Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	7.447E+00	0.024	19	31	201	206	35	217	218	211	0.830	0.839
LOKIASV2_1571_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_A	8du9-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	6.762E+00	0.024	19	30	187	206	50	201	221	180	0.767	0.688
LOKIASV2_1571_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_A	6pfm-assembly1.cif.gz_A Crystal structure of GDC-0927 bound to estrogen receptor alpha	8.201E+00	0.024	19	17	187	206	24	217	224	217	0.830	0.866
LOKIASV2_1571_ESMFold_hypothetical_protein	7trb-assembly1.cif.gz_A	7trb-assembly1.cif.gz_A CRYSTAL STRUCTURE OF FARNESOID X-ACTIVATED RECEPTOR COMPLEXED WITH COMPOUND-32 AKA (1S,3S)-N-({4-[5-(2-FLUOROPR OPAN-2-YL)-1,2,4-OXADIAZOL-3-YL]BICYCLO[2.2.2]OCTAN-1-YL}M ETHYL)-3-HYDROXY-N-[4'-(2-HYDROXYPROPAN-2-YL)-[1,1'-BIPHEN YL]-3-YL]-3-(TRIFLUOROMETHYL)CYCLOBUTANE-1-CARBOXAMIDE	7.815E+00	0.024	19	26	199	206	65	210	225	178	0.845	0.649
LOKIASV2_1571_ESMFold_hypothetical_protein	1pzl-assembly1.cif.gz_A	1pzl-assembly1.cif.gz_A Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide	7.815E+00	0.024	19	27	206	206	60	216	227	193	0.874	0.692
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_D	7ujy-assembly2.cif.gz_D Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	9.947E+00	0.024	19	30	200	206	72	226	227	184	0.830	0.683
LOKIASV2_1571_ESMFold_hypothetical_protein	1qkn-assembly1.cif.gz_A-2	1qkn-assembly1.cif.gz_A-2 RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE	7.815E+00	0.024	19	30	201	206	41	227	228	208	0.835	0.820
LOKIASV2_1571_ESMFold_hypothetical_protein	4avm-assembly1.cif.gz_A-2	4avm-assembly1.cif.gz_A-2 Crystal structure of the N-BAR domain of human bridging integrator 2.	7.815E+00	0.024	19	29	201	206	48	221	230	184	0.840	0.757
LOKIASV2_1571_ESMFold_hypothetical_protein	5tld-assembly1.cif.gz_A	5tld-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	7.447E+00	0.024	19	30	201	206	39	227	230	220	0.835	0.822
LOKIASV2_1571_ESMFold_hypothetical_protein	6wok-assembly2.cif.gz_B	6wok-assembly2.cif.gz_B Crystal structure of estrogen receptor alpha in complex with receptor degrader 6	5.851E+00	0.024	19	17	187	206	25	211	230	211	0.830	0.813
LOKIASV2_1571_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_A	5wgq-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1	8.201E+00	0.024	19	27	200	206	61	217	231	188	0.845	0.680
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_A	1pq9-assembly1.cif.gz_A HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	5.313E+00	0.024	19	26	205	206	1	226	232	241	0.874	0.974
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_A	2r6y-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain in complex with a SERM	4.597E+00	0.024	19	26	200	206	25	227	232	224	0.850	0.875
LOKIASV2_1571_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_D	3kfc-assembly2.cif.gz_D Complex Structure of LXR with an agonist	5.062E+00	0.024	19	26	200	206	1	231	233	243	0.850	0.991
LOKIASV2_1571_ESMFold_hypothetical_protein	5dzh-assembly1.cif.gz_B	5dzh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	9.032E+00	0.024	19	20	185	206	26	205	235	198	0.806	0.766
LOKIASV2_1571_ESMFold_hypothetical_protein	5gs4-assembly1.cif.gz_A	5gs4-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with a stabilized peptide antagonist	7.096E+00	0.024	19	30	201	206	69	234	236	193	0.835	0.703
LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly2.cif.gz_A	6vpf-assembly2.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene	6.762E+00	0.024	19	17	185	206	24	209	236	216	0.820	0.788
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs3-assembly2.cif.gz_D	7rs3-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29	7.096E+00	0.024	19	19	187	206	28	216	237	215	0.820	0.797
LOKIASV2_1571_ESMFold_hypothetical_protein	1p8d-assembly3.cif.gz_B	1p8d-assembly3.cif.gz_B X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol	7.096E+00	0.024	19	26	204	206	75	226	239	184	0.869	0.636
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_A	6sbo-assembly1.cif.gz_A Estrogen receptor mutant L536S	7.815E+00	0.024	19	30	185	206	55	207	239	181	0.757	0.640
LOKIASV2_1571_ESMFold_hypothetical_protein	5dkg-assembly1.cif.gz_B	5dkg-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol	7.447E+00	0.024	19	17	201	206	26	236	240	227	0.898	0.879
LOKIASV2_1571_ESMFold_hypothetical_protein	3plz-assembly2.cif.gz_B	3plz-assembly2.cif.gz_B Human LRH1 LBD bound to GR470	6.762E+00	0.024	19	30	196	206	48	223	240	200	0.811	0.733
LOKIASV2_1571_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_A	5t1z-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide	8.201E+00	0.024	19	26	200	206	66	224	240	190	0.850	0.663
LOKIASV2_1571_ESMFold_hypothetical_protein	5tm7-assembly1.cif.gz_B	5tm7-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid	8.201E+00	0.024	19	66	201	206	74	237	240	167	0.660	0.683
LOKIASV2_1571_ESMFold_hypothetical_protein	3l0e-assembly1.cif.gz_A	3l0e-assembly1.cif.gz_A X-ray crystal structure of a Potent Liver X Receptor Modulator	8.201E+00	0.024	19	34	180	206	83	216	243	152	0.714	0.551
LOKIASV2_1571_ESMFold_hypothetical_protein	2qab-assembly1.cif.gz_B	2qab-assembly1.cif.gz_B Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound	6.762E+00	0.024	19	27	200	206	67	229	245	194	0.845	0.665
LOKIASV2_1571_ESMFold_hypothetical_protein	8hhq-assembly1.cif.gz_B-2	8hhq-assembly1.cif.gz_B-2 Covalent bond formation between cysteine of PPARg-LBD and iodoacetic acid	6.140E+00	0.024	19	26	200	206	90	247	249	187	0.850	0.635
LOKIASV2_1571_ESMFold_hypothetical_protein	4hee-assembly1.cif.gz_X	4hee-assembly1.cif.gz_X Crystal structure of PPARgamma in complex with compound 13	8.606E+00	0.024	19	27	195	206	85	230	251	172	0.820	0.582
LOKIASV2_1571_ESMFold_hypothetical_protein	1rdt-assembly1.cif.gz_D	1rdt-assembly1.cif.gz_D Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer	7.096E+00	0.024	19	29	206	206	63	240	253	206	0.864	0.704
LOKIASV2_1571_ESMFold_hypothetical_protein	5f9b-assembly1.cif.gz_A	5f9b-assembly1.cif.gz_A X-ray crystal structure of PPARgamma in the complex with caulophyllogenin	7.815E+00	0.024	19	26	199	206	89	239	254	177	0.845	0.594
LOKIASV2_1571_ESMFold_hypothetical_protein	3ia6-assembly2.cif.gz_B-2	3ia6-assembly2.cif.gz_B-2 X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist	7.096E+00	0.024	19	26	203	206	94	248	255	182	0.864	0.608
LOKIASV2_1571_ESMFold_hypothetical_protein	7efq-assembly1.cif.gz_A	7efq-assembly1.cif.gz_A Crystal structure of hPPARgamma ligand binding domain complexed with rosiglitazone-based fluorescence probe	7.447E+00	0.024	19	27	198	206	91	244	256	177	0.835	0.602
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv1-assembly1.cif.gz_A	2vv1-assembly1.cif.gz_A hPPARgamma Ligand binding domain in complex with 4-HDHA	8.201E+00	0.024	19	27	199	206	90	240	256	178	0.840	0.590
LOKIASV2_1571_ESMFold_hypothetical_protein	3adt-assembly2.cif.gz_B-2	3adt-assembly2.cif.gz_B-2 Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate	5.313E+00	0.024	19	27	204	206	95	246	257	182	0.864	0.591
LOKIASV2_1571_ESMFold_hypothetical_protein	4r2u-assembly2.cif.gz_D-2	4r2u-assembly2.cif.gz_D-2 Crystal Structure of PPARgamma in complex with SR1664	8.606E+00	0.024	19	26	201	206	96	256	257	183	0.854	0.626
LOKIASV2_1571_ESMFold_hypothetical_protein	1nyx-assembly1.cif.gz_B	1nyx-assembly1.cif.gz_B Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist	6.140E+00	0.024	19	29	198	206	101	256	258	180	0.825	0.605
LOKIASV2_1571_ESMFold_hypothetical_protein	8bf1-assembly1.cif.gz_A	8bf1-assembly1.cif.gz_A High-resolution structure of unliganded PPAR gamma in complex with the peptide PGC-1 alpha	8.201E+00	0.024	19	27	199	206	97	245	262	176	0.840	0.569
LOKIASV2_1571_ESMFold_hypothetical_protein	3gz9-assembly1.cif.gz_A	3gz9-assembly1.cif.gz_A Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Complex with a Full Agonist	6.762E+00	0.024	19	29	199	206	102	245	262	173	0.830	0.550
LOKIASV2_1571_ESMFold_hypothetical_protein	6c1i-assembly1.cif.gz_A	6c1i-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907	6.443E+00	0.024	19	26	199	206	96	246	263	178	0.845	0.574
LOKIASV2_1571_ESMFold_hypothetical_protein	6d3e-assembly1.cif.gz_A	6d3e-assembly1.cif.gz_A PPARg LBD in Complex with SR1988	7.447E+00	0.024	19	26	203	206	96	262	263	189	0.864	0.635
LOKIASV2_1571_ESMFold_hypothetical_protein	6d3e-assembly1.cif.gz_B-2	6d3e-assembly1.cif.gz_B-2 PPARg LBD in Complex with SR1988	8.201E+00	0.024	19	26	203	206	100	254	263	181	0.864	0.589
LOKIASV2_1571_ESMFold_hypothetical_protein	8hhp-assembly1.cif.gz_A	8hhp-assembly1.cif.gz_A Crystal structure of PPARg-LBD complexed with three partial agonists, one nTZDpa and two LT175	7.096E+00	0.024	19	34	206	206	101	250	263	178	0.840	0.570
LOKIASV2_1571_ESMFold_hypothetical_protein	3wmh-assembly1.cif.gz_A	3wmh-assembly1.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gammma selective synthetic partial agonist MEKT75	6.762E+00	0.024	19	26	198	206	97	250	264	183	0.840	0.583
LOKIASV2_1571_ESMFold_hypothetical_protein	3vsp-assembly1.cif.gz_A	3vsp-assembly1.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt28	8.606E+00	0.024	19	26	206	206	98	255	265	184	0.879	0.596
LOKIASV2_1571_ESMFold_hypothetical_protein	8b8x-assembly1.cif.gz_A	8b8x-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist	7.096E+00	0.024	19	27	188	206	104	250	268	167	0.786	0.549
LOKIASV2_1571_ESMFold_hypothetical_protein	6c5t-assembly1.cif.gz_A	6c5t-assembly1.cif.gz_A PPARg LBD bound to SR11023	8.606E+00	0.024	19	30	200	206	106	254	270	176	0.830	0.552
LOKIASV2_1571_ESMFold_hypothetical_protein	6t1s-assembly1.cif.gz_A-2	6t1s-assembly1.cif.gz_A-2 PPAR mutant	5.851E+00	0.024	19	27	204	206	107	257	274	188	0.864	0.551
LOKIASV2_1571_ESMFold_hypothetical_protein	4c9j-assembly1.cif.gz_A	4c9j-assembly1.cif.gz_A Structure of yeast mitochondrial ADP/ATP carrier isoform 3 inhibited by carboxyatractyloside (P212121 crystal form)	9.032E+00	0.024	19	29	198	206	78	274	277	230	0.825	0.711
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbd-assembly1.cif.gz_A	6sbd-assembly1.cif.gz_A Structure of type II terpene cyclase MstE_D109A from Scytonema in complex with merosterolic acid A (product)	7.815E+00	0.024	19	27	116	206	1	107	346	110	0.437	0.309
LOKIASV2_1571_ESMFold_hypothetical_protein	3dzy-assembly1.cif.gz_D	3dzy-assembly1.cif.gz_D Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide	6.140E+00	0.024	19	31	204	206	189	337	354	179	0.845	0.421
LOKIASV2_1571_ESMFold_hypothetical_protein	4zyr-assembly2.cif.gz_B	4zyr-assembly2.cif.gz_B Crystal structure of E. coli Lactose permease G46W/G262W bound to p-nitrophenyl alpha-D-galactopyranoside (alpha-NPG)	5.575E+00	0.024	19	30	185	206	50	182	385	165	0.757	0.345
LOKIASV2_1571_ESMFold_hypothetical_protein	5ww3-assembly1.cif.gz_A	5ww3-assembly1.cif.gz_A Crystal structure of the second DNA-Binding protein under starvation from Mycobacterium smegmatis soaked with iron in the ratio of 24 iron atoms per dodecamer	9.478E+00	0.020	18	3	196	206	1	158	161	208	0.942	0.981
LOKIASV2_1571_ESMFold_hypothetical_protein	6yj2-assembly1.cif.gz_A	6yj2-assembly1.cif.gz_A Structural and DNA binding studies of the transcriptional repressor Rv2506 (BkaR) from Mycobacterium tuberculosis supports a role in L-Leucine catabolism	7.815E+00	0.020	18	66	191	206	3	134	186	138	0.612	0.710
LOKIASV2_1571_ESMFold_hypothetical_protein	4ozt-assembly1.cif.gz_U	4ozt-assembly1.cif.gz_U crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (PonA crystal)	8.606E+00	0.020	18	31	184	206	3	169	195	184	0.748	0.856
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_D	7rry-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	9.478E+00	0.020	18	30	195	206	62	205	209	176	0.806	0.689
LOKIASV2_1571_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_B	2q70-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand	7.815E+00	0.020	18	31	185	206	31	201	211	197	0.752	0.810
LOKIASV2_1571_ESMFold_hypothetical_protein	5i4v-assembly1.cif.gz_B	5i4v-assembly1.cif.gz_B Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists	6.140E+00	0.020	18	28	200	206	40	210	215	199	0.840	0.795
LOKIASV2_1571_ESMFold_hypothetical_protein	6a5z-assembly1.cif.gz_A	6a5z-assembly1.cif.gz_A Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1	8.201E+00	0.020	18	29	183	206	47	196	220	173	0.752	0.682
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_D	6dfn-assembly2.cif.gz_D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	6.443E+00	0.020	18	25	201	206	22	220	221	222	0.859	0.900
LOKIASV2_1571_ESMFold_hypothetical_protein	5q0m-assembly1.cif.gz_A	5q0m-assembly1.cif.gz_A Ligand binding to FARNESOID-X-RECEPTOR	7.815E+00	0.020	18	45	188	206	75	208	223	158	0.699	0.601
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs9-assembly2.cif.gz_D	7rs9-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25	9.478E+00	0.020	18	30	205	206	58	211	224	194	0.854	0.688
LOKIASV2_1571_ESMFold_hypothetical_protein	6c42-assembly1.cif.gz_B	6c42-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1156	6.762E+00	0.020	18	26	187	206	27	201	225	208	0.786	0.778
LOKIASV2_1571_ESMFold_hypothetical_protein	5dyd-assembly1.cif.gz_A	5dyd-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol	7.447E+00	0.020	18	66	201	206	68	222	225	166	0.660	0.689
LOKIASV2_1571_ESMFold_hypothetical_protein	6itm-assembly1.cif.gz_A	6itm-assembly1.cif.gz_A Crystal structure of FXR in complex with agonist XJ034	8.606E+00	0.020	18	30	180	206	40	199	225	184	0.733	0.711
LOKIASV2_1571_ESMFold_hypothetical_protein	1lv2-assembly1.cif.gz_A	1lv2-assembly1.cif.gz_A Hepatocyte Nuclear Factor 4 is a Transcription Factor that Constitutively Binds Fatty Acids	7.815E+00	0.020	18	28	206	206	61	215	225	186	0.869	0.689
LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly2.cif.gz_D	5w9c-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen	6.140E+00	0.020	18	25	187	206	26	208	227	206	0.791	0.806
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_B	7rrz-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	8.606E+00	0.020	18	30	187	206	64	210	229	174	0.767	0.642
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_C	7rs8-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	5.851E+00	0.020	18	17	187	206	25	211	229	216	0.830	0.817
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujc-assembly1.cif.gz_A	7ujc-assembly1.cif.gz_A Raloxifene in Complex with Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutation	7.815E+00	0.020	18	26	204	206	27	228	229	223	0.869	0.882
LOKIASV2_1571_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_B	5wgq-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1	7.447E+00	0.020	18	24	200	206	60	214	229	193	0.859	0.677
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly1.cif.gz_B	7rs2-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	9.032E+00	0.020	18	34	200	206	55	217	230	191	0.811	0.709
LOKIASV2_1571_ESMFold_hypothetical_protein	6owc-assembly1.cif.gz_A	6owc-assembly1.cif.gz_A Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545.	8.606E+00	0.020	18	25	201	206	26	231	232	232	0.859	0.888
LOKIASV2_1571_ESMFold_hypothetical_protein	8du8-assembly1.cif.gz_A	8du8-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	6.140E+00	0.020	18	26	187	206	29	212	233	206	0.786	0.790
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_A	6dfn-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	6.762E+00	0.020	18	30	201	206	41	233	234	211	0.835	0.825
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly2.cif.gz_D	7rs2-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	6.140E+00	0.020	18	30	205	206	60	221	234	198	0.854	0.692
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4u-assembly1.cif.gz_A	6s4u-assembly1.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	7.447E+00	0.020	18	27	205	206	3	229	236	240	0.869	0.962
LOKIASV2_1571_ESMFold_hypothetical_protein	4j5x-assembly1.cif.gz_D	4j5x-assembly1.cif.gz_D Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex	5.313E+00	0.020	18	29	201	206	6	213	239	221	0.840	0.870
LOKIASV2_1571_ESMFold_hypothetical_protein	4rup-assembly1.cif.gz_A-2	4rup-assembly1.cif.gz_A-2 Crystal structure of zVDR L337H mutant-Gemini72 complex	5.851E+00	0.020	18	24	184	206	69	209	239	173	0.782	0.590
LOKIASV2_1571_ESMFold_hypothetical_protein	1a52-assembly1.cif.gz_B	1a52-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL	9.947E+00	0.020	18	27	205	206	67	232	240	196	0.869	0.692
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_B	6sbo-assembly1.cif.gz_B Estrogen receptor mutant L536S	9.032E+00	0.020	18	17	206	206	25	242	242	237	0.922	0.901
LOKIASV2_1571_ESMFold_hypothetical_protein	3b0r-assembly1.cif.gz_B	3b0r-assembly1.cif.gz_B Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form	8.606E+00	0.020	18	29	200	206	94	244	245	176	0.835	0.616
LOKIASV2_1571_ESMFold_hypothetical_protein	5i4v-assembly2.cif.gz_E	5i4v-assembly2.cif.gz_E Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists	6.762E+00	0.020	18	27	205	206	4	239	245	242	0.869	0.963
LOKIASV2_1571_ESMFold_hypothetical_protein	3osi-assembly2.cif.gz_B	3osi-assembly2.cif.gz_B Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA)	7.447E+00	0.020	18	27	194	206	85	234	245	174	0.816	0.612
LOKIASV2_1571_ESMFold_hypothetical_protein	2q5p-assembly1.cif.gz_B	2q5p-assembly1.cif.gz_B Crystal Structure of PPARgamma bound to partial agonist MRL24	7.447E+00	0.020	18	27	194	206	87	240	245	176	0.816	0.629
LOKIASV2_1571_ESMFold_hypothetical_protein	5tn1-assembly1.cif.gz_A	5tn1-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,E)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	7.815E+00	0.020	18	22	200	206	30	230	245	221	0.869	0.820
LOKIASV2_1571_ESMFold_hypothetical_protein	7e2o-assembly2.cif.gz_B	7e2o-assembly2.cif.gz_B X-ray Crystal structure of PPARgamma R288H mutant.	6.762E+00	0.020	18	27	205	206	88	240	246	184	0.869	0.622
LOKIASV2_1571_ESMFold_hypothetical_protein	1nuo-assembly1.cif.gz_A	1nuo-assembly1.cif.gz_A Two RTH Mutants with Impaired Hormone Binding	8.201E+00	0.020	18	30	200	206	89	246	247	187	0.830	0.640
LOKIASV2_1571_ESMFold_hypothetical_protein	2vst-assembly2.cif.gz_B	2vst-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 13-(S)-HODE	8.606E+00	0.020	18	29	204	206	95	248	248	178	0.854	0.621
LOKIASV2_1571_ESMFold_hypothetical_protein	1y2o-assembly1.cif.gz_B	1y2o-assembly1.cif.gz_B Structure of N-terminal domain IRSp53/BAIAP2	4.824E+00	0.020	18	29	194	206	38	227	248	202	0.806	0.766
LOKIASV2_1571_ESMFold_hypothetical_protein	2awh-assembly1.cif.gz_B	2awh-assembly1.cif.gz_B Human Nuclear Receptor-Ligand Complex 1	8.606E+00	0.020	18	26	187	206	83	222	250	167	0.786	0.560
LOKIASV2_1571_ESMFold_hypothetical_protein	2zno-assembly2.cif.gz_B-2	2zno-assembly2.cif.gz_B-2 Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703	6.762E+00	0.020	18	32	204	206	93	242	251	181	0.840	0.598
LOKIASV2_1571_ESMFold_hypothetical_protein	2j14-assembly1.cif.gz_A	2j14-assembly1.cif.gz_A 3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2	7.447E+00	0.020	18	30	187	206	83	226	253	169	0.767	0.569
LOKIASV2_1571_ESMFold_hypothetical_protein	2q8s-assembly1.cif.gz_B	2q8s-assembly1.cif.gz_B X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist	7.096E+00	0.020	18	26	201	206	93	253	254	185	0.854	0.634
LOKIASV2_1571_ESMFold_hypothetical_protein	7cxe-assembly1.cif.gz_B-2	7cxe-assembly1.cif.gz_B-2 The ligand-free structure of human PPARgamma LBD R280C mutant	6.762E+00	0.020	18	27	204	206	90	241	255	183	0.864	0.596
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgo-assembly1.cif.gz_B	6dgo-assembly1.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone	7.447E+00	0.020	18	32	203	206	96	248	256	180	0.835	0.598
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgl-assembly2.cif.gz_B	6dgl-assembly2.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Darglitazone	7.815E+00	0.020	18	26	201	206	96	255	257	182	0.854	0.623
LOKIASV2_1571_ESMFold_hypothetical_protein	1i7i-assembly2.cif.gz_B	1i7i-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242	7.815E+00	0.020	18	29	204	206	98	247	258	189	0.854	0.581
LOKIASV2_1571_ESMFold_hypothetical_protein	3sz1-assembly2.cif.gz_B	3sz1-assembly2.cif.gz_B Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid	8.201E+00	0.020	18	26	204	206	93	244	258	182	0.869	0.589
LOKIASV2_1571_ESMFold_hypothetical_protein	2znn-assembly1.cif.gz_A	2znn-assembly1.cif.gz_A Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703	9.947E+00	0.020	18	31	198	206	97	239	258	170	0.816	0.554
LOKIASV2_1571_ESMFold_hypothetical_protein	3et0-assembly2.cif.gz_B	3et0-assembly2.cif.gz_B Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid	9.478E+00	0.020	18	26	205	206	92	252	259	184	0.874	0.622
LOKIASV2_1571_ESMFold_hypothetical_protein	8huk-assembly1.cif.gz_A	8huk-assembly1.cif.gz_A X-ray structure of human PPAR alpha ligand binding domain-lanifibranor-SRC1 coactivator peptide co-crystals obtained by soaking	9.478E+00	0.020	18	26	204	206	91	242	259	183	0.869	0.587
LOKIASV2_1571_ESMFold_hypothetical_protein	7e0a-assembly1.cif.gz_A	7e0a-assembly1.cif.gz_A X-ray structure of human PPARgamma ligand binding domain-saroglitazar co-crystals obtained by co-crystallization	8.201E+00	0.020	18	29	206	206	106	257	267	180	0.864	0.569
LOKIASV2_1571_ESMFold_hypothetical_protein	6fzf-assembly1.cif.gz_A	6fzf-assembly1.cif.gz_A PPAR mutant complex	9.478E+00	0.020	18	26	204	206	103	254	271	182	0.869	0.561
LOKIASV2_1571_ESMFold_hypothetical_protein	8ium-assembly1.cif.gz_R	8ium-assembly1.cif.gz_R Cryo-EM structure of the tafluprost acid-bound human PTGFR-Gq complex	6.762E+00	0.020	18	36	188	206	2	143	293	172	0.743	0.485
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbe-assembly1.cif.gz_A	6sbe-assembly1.cif.gz_A Structure of type II terpene cyclase MstE_D109N from Scytonema in complex with geranylgeranyl dihydroxybenzoate (substrate)	5.575E+00	0.020	18	27	153	206	1	122	352	148	0.617	0.347
LOKIASV2_1571_ESMFold_hypothetical_protein	2x0l-assembly1.cif.gz_A	2x0l-assembly1.cif.gz_A Crystal structure of a neuro-specific splicing variant of human histone lysine demethylase LSD1.	7.447E+00	0.020	18	26	176	206	204	347	670	154	0.733	0.215
LOKIASV2_1571_ESMFold_hypothetical_protein	4m34-assembly1.cif.gz_A	4m34-assembly1.cif.gz_A Crystal structure of gated-pore mutant D138H of second DNA-Binding protein under starvation from Mycobacterium smegmatis	9.032E+00	0.016	17	6	196	206	3	157	160	203	0.927	0.969
LOKIASV2_1571_ESMFold_hypothetical_protein	6cht-assembly2.cif.gz_H	6cht-assembly2.cif.gz_H HNF4alpha in complex with the corepressor EBP1 fragment	6.140E+00	0.016	17	27	201	206	38	194	202	192	0.850	0.777
LOKIASV2_1571_ESMFold_hypothetical_protein	7vg5-assembly1.cif.gz_B	7vg5-assembly1.cif.gz_B 10,5-methenyltetrahydrofolate cyclohydrolase from Methylobacterium extorquens AM1 with tetrahydrofolate	5.575E+00	0.016	17	30	194	206	19	197	204	194	0.801	0.877
LOKIASV2_1571_ESMFold_hypothetical_protein	7e1n-assembly1.cif.gz_B	7e1n-assembly1.cif.gz_B Crystal structure of PhlH in complex with 2,4-diacetylphloroglucinol	9.478E+00	0.016	17	30	194	206	49	203	205	177	0.801	0.756
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly2.cif.gz_A	7ujw-assembly2.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	7.815E+00	0.016	17	25	200	206	22	209	210	216	0.854	0.895
LOKIASV2_1571_ESMFold_hypothetical_protein	3l1b-assembly1.cif.gz_A	3l1b-assembly1.cif.gz_A Complex Structure of FXR Ligand-binding domain with a tetrahydroazepinoindole compound	9.478E+00	0.016	17	29	202	206	34	216	216	209	0.845	0.847
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly2.cif.gz_D	1pq9-assembly2.cif.gz_D HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	7.815E+00	0.016	17	29	205	206	10	213	219	222	0.859	0.932
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_B	2r6y-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain in complex with a SERM	7.815E+00	0.016	17	30	200	206	50	220	221	201	0.830	0.774
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_B	7rry-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	9.032E+00	0.016	17	25	187	206	23	208	221	216	0.791	0.842
LOKIASV2_1571_ESMFold_hypothetical_protein	3ols-assembly2.cif.gz_B	3ols-assembly2.cif.gz_B Crystal structure of estrogen receptor beta ligand binding domain	8.606E+00	0.016	17	30	201	206	69	212	224	178	0.835	0.643
LOKIASV2_1571_ESMFold_hypothetical_protein	5y44-assembly1.cif.gz_A	5y44-assembly1.cif.gz_A A novel moderator XD4 for bile acid receptor	8.606E+00	0.016	17	21	180	206	31	196	224	189	0.777	0.741
LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly1.cif.gz_A	7msa-assembly1.cif.gz_A GDC-9545 in complex with estrogen receptor alpha	7.096E+00	0.016	17	30	187	206	41	207	225	193	0.767	0.742
LOKIASV2_1571_ESMFold_hypothetical_protein	8dug-assembly1.cif.gz_A	8dug-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-((<i>S</i>)-3-methylpyrrolidin-1-yl)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	7.815E+00	0.016	17	24	185	206	23	203	227	202	0.786	0.797
LOKIASV2_1571_ESMFold_hypothetical_protein	8dui-assembly1.cif.gz_A	8dui-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(dimethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	9.947E+00	0.016	17	30	187	206	67	207	227	169	0.767	0.621
LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_D	5tnb-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	9.478E+00	0.016	17	30	201	206	41	226	227	218	0.835	0.819
LOKIASV2_1571_ESMFold_hypothetical_protein	1u3s-assembly1.cif.gz_A	1u3s-assembly1.cif.gz_A Crystal Structure of Estrogen Receptor beta complexed with WAY-797	8.201E+00	0.016	17	30	201	206	39	213	227	200	0.835	0.771
LOKIASV2_1571_ESMFold_hypothetical_protein	4is8-assembly2.cif.gz_B	4is8-assembly2.cif.gz_B Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors	9.947E+00	0.016	17	20	200	206	28	220	230	216	0.879	0.839
LOKIASV2_1571_ESMFold_hypothetical_protein	2qa8-assembly1.cif.gz_A	2qa8-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein	8.606E+00	0.016	17	31	200	206	36	215	230	210	0.825	0.783
LOKIASV2_1571_ESMFold_hypothetical_protein	1u3r-assembly1.cif.gz_A	1u3r-assembly1.cif.gz_A Crystal Structure of Estrogen Receptor beta complexed with WAY-338	7.096E+00	0.016	17	30	201	206	39	214	231	205	0.835	0.762
LOKIASV2_1571_ESMFold_hypothetical_protein	7ndo-assembly1.cif.gz_B	7ndo-assembly1.cif.gz_B ER-PRS*(-) (L536S, L372R) in complex with raloxifene	9.947E+00	0.016	17	18	187	206	21	212	237	215	0.825	0.810
LOKIASV2_1571_ESMFold_hypothetical_protein	8dvb-assembly1.cif.gz_A	8dvb-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-((1-butylpyrrolidin-3-yl)methoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	7.447E+00	0.016	17	19	187	206	24	215	240	215	0.820	0.800
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_D-2	7ujo-assembly2.cif.gz_D-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	9.947E+00	0.016	17	19	205	206	25	226	240	235	0.908	0.842
LOKIASV2_1571_ESMFold_hypothetical_protein	7kbs-assembly1.cif.gz_A	7kbs-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene	8.201E+00	0.016	17	19	187	206	24	215	242	216	0.820	0.793
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_C	7rs7-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	7.096E+00	0.016	17	19	201	206	26	237	244	233	0.888	0.869
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9m-assembly2.cif.gz_D	6k9m-assembly2.cif.gz_D Human LXR-beta in complex with an agonist	9.478E+00	0.016	17	27	185	206	71	207	245	172	0.772	0.559
LOKIASV2_1571_ESMFold_hypothetical_protein	1zeo-assembly1.cif.gz_B	1zeo-assembly1.cif.gz_B Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist	9.947E+00	0.016	17	27	201	206	86	246	247	184	0.850	0.652
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9g-assembly1.cif.gz_A	6k9g-assembly1.cif.gz_A Human LXR-beta in complex with an agonist	8.201E+00	0.016	17	26	205	206	1	246	249	247	0.874	0.988
LOKIASV2_1571_ESMFold_hypothetical_protein	3po9-assembly2.cif.gz_B	3po9-assembly2.cif.gz_B Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin	9.947E+00	0.016	17	26	200	206	86	244	249	183	0.850	0.639
LOKIASV2_1571_ESMFold_hypothetical_protein	4r06-assembly1.cif.gz_A	4r06-assembly1.cif.gz_A Crystal Structure of SR2067 bound to PPARgamma	9.478E+00	0.016	17	26	204	206	86	237	252	182	0.869	0.603
LOKIASV2_1571_ESMFold_hypothetical_protein	6an1-assembly1.cif.gz_B	6an1-assembly1.cif.gz_B Crystal structure of the complex between PPARgamma LBD and the ligand AM-879	9.478E+00	0.016	17	26	187	206	93	235	253	166	0.786	0.565
LOKIASV2_1571_ESMFold_hypothetical_protein	8b8y-assembly1.cif.gz_A	8b8y-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7e)	9.032E+00	0.016	17	28	199	206	98	247	254	177	0.835	0.591
LOKIASV2_1571_ESMFold_hypothetical_protein	6icj-assembly1.cif.gz_A	6icj-assembly1.cif.gz_A Crystal structure of PPARgamma with compound BR102375K	9.478E+00	0.016	17	29	204	206	89	238	254	181	0.854	0.591
LOKIASV2_1571_ESMFold_hypothetical_protein	3cwd-assembly1.cif.gz_A	3cwd-assembly1.cif.gz_A Molecular recognition of nitro-fatty acids by PPAR gamma	8.606E+00	0.016	17	26	204	206	89	240	257	182	0.869	0.591
LOKIASV2_1571_ESMFold_hypothetical_protein	6md1-assembly2.cif.gz_B	6md1-assembly2.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid	9.947E+00	0.016	17	26	201	206	95	256	257	185	0.854	0.630
LOKIASV2_1571_ESMFold_hypothetical_protein	7bq2-assembly1.cif.gz_A	7bq2-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-pemafibrate-SRC1 coactivator peptide co-crystals obtained by soaking	9.478E+00	0.016	17	26	204	206	91	242	259	183	0.869	0.587
LOKIASV2_1571_ESMFold_hypothetical_protein	6dbh-assembly2.cif.gz_B	6dbh-assembly2.cif.gz_B Crystal structure of PPAR gamma in complex with NMP422	8.606E+00	0.016	17	26	204	206	97	248	259	187	0.869	0.587
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgo-assembly1.cif.gz_A	6dgo-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone	9.947E+00	0.016	17	34	199	206	101	245	260	171	0.806	0.558
LOKIASV2_1571_ESMFold_hypothetical_protein	8dsz-assembly1.cif.gz_B	8dsz-assembly1.cif.gz_B PPARg bound to partial agonist H3B-487	9.032E+00	0.016	17	26	187	206	95	237	261	166	0.786	0.548
LOKIASV2_1571_ESMFold_hypothetical_protein	2zk1-assembly1.cif.gz_B	2zk1-assembly1.cif.gz_B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2	9.032E+00	0.016	17	26	204	206	103	254	263	183	0.869	0.578
LOKIASV2_1571_ESMFold_hypothetical_protein	3ncy-assembly1.cif.gz_B	3ncy-assembly1.cif.gz_B X-ray crystal structure of an arginine agmatine antiporter (AdiC) in complex with a Fab fragment	9.947E+00	0.016	17	80	201	206	278	401	420	136	0.592	0.295
LOKIASV2_1571_ESMFold_hypothetical_protein	4m34-assembly1.cif.gz_C	4m34-assembly1.cif.gz_C Crystal structure of gated-pore mutant D138H of second DNA-Binding protein under starvation from Mycobacterium smegmatis	9.478E+00	0.014	16	18	196	206	2	153	156	191	0.869	0.974
LOKIASV2_1571_ESMFold_hypothetical_protein	7jg5-assembly1.cif.gz_a	7jg5-assembly1.cif.gz_a Cryo-EM structure of bedaquiline-free Mycobacterium smegmatis ATP synthase rotational state 1	5.313E+00	0.014	16	27	185	206	56	206	207	177	0.772	0.729
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_D	7rs8-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	9.947E+00	0.014	16	25	181	206	25	193	217	196	0.762	0.779
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxp-assembly1.cif.gz_A	5dxp-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol	9.478E+00	0.014	16	31	206	206	34	212	222	217	0.854	0.806
LOKIASV2_1571_ESMFold_hypothetical_protein	7qvl-assembly2.cif.gz_B	7qvl-assembly2.cif.gz_B OESTROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH COMPOUND 38	8.201E+00	0.014	16	30	200	206	57	213	225	188	0.830	0.698
LOKIASV2_1571_ESMFold_hypothetical_protein	4znh-assembly1.cif.gz_B	4znh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substituted OBHS derivative	9.947E+00	0.014	16	26	201	206	62	224	227	200	0.854	0.718
LOKIASV2_1571_ESMFold_hypothetical_protein	5ufw-assembly1.cif.gz_A	5ufw-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1154	9.032E+00	0.014	16	19	184	206	22	209	237	213	0.806	0.793
LOKIASV2_1571_ESMFold_hypothetical_protein	8b93-assembly1.cif.gz_A	8b93-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 15b)	9.947E+00	0.014	16	27	204	206	97	247	248	183	0.864	0.609
LOKIASV2_1571_ESMFold_hypothetical_protein	5kyj-assembly1.cif.gz_A	5kyj-assembly1.cif.gz_A Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	9.478E+00	0.014	16	24	205	206	1	245	251	251	0.883	0.976
LOKIASV2_1571_ESMFold_hypothetical_protein	4r6s-assembly2.cif.gz_B-2	4r6s-assembly2.cif.gz_B-2 Crystal structure of PPARgammma in complex with SR1663	9.478E+00	0.014	16	26	204	206	93	244	254	190	0.869	0.598
LOKIASV2_1571_ESMFold_hypothetical_protein	6wh4-assembly1.cif.gz_A	6wh4-assembly1.cif.gz_A Crystal structure of HTR2A with inverse agonist	6.140E+00	0.014	16	30	204	206	2	147	378	184	0.850	0.386
LOKIASV2_1571_ESMFold_hypothetical_protein	6p25-assembly1.cif.gz_A	6p25-assembly1.cif.gz_A Structure of S. cerevisiae protein O-mannosyltransferase Pmt1-Pmt2 complex bound to the sugar donor and a peptide acceptor	3.977E+00	0.014	16	29	185	206	125	282	731	185	0.762	0.216
LOKIASV2_1571_ESMFold_hypothetical_protein	8dub-assembly1.cif.gz_B	8dub-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with ((1'-(4-((1-ethylpyrrolidin-3-yl)methyl)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	9.947E+00	0.011	15	25	181	206	20	194	218	202	0.762	0.803
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9g-assembly1.cif.gz_C	6k9g-assembly1.cif.gz_C Human LXR-beta in complex with an agonist	9.947E+00	0.011	15	29	201	206	11	216	225	214	0.840	0.916
LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly1.cif.gz_A	6jio-assembly1.cif.gz_A Human LXR-beta in complex with a ligand	8.606E+00	0.011	15	26	188	206	3	209	244	224	0.791	0.848
LOKIASV2_1571_ESMFold_hypothetical_protein	4r2u-assembly2.cif.gz_A	4r2u-assembly2.cif.gz_A Crystal Structure of PPARgamma in complex with SR1664	9.478E+00	0.011	15	26	204	206	93	244	260	191	0.869	0.585
LOKIASV2_1571_ESMFold_hypothetical_protein	2efk-assembly1.cif.gz_A-2	2efk-assembly1.cif.gz_A-2 Crystal structure of the EFC domain of Cdc42-interacting protein 4	4.597E+00	0.011	15	29	201	206	12	238	273	234	0.840	0.832
LOKIASV2_1571_ESMFold_hypothetical_protein	5x5y-assembly1.cif.gz_G	5x5y-assembly1.cif.gz_G A membrane protein complex	9.947E+00	0.011	15	29	204	206	10	139	351	180	0.854	0.370
LOKIASV2_1571_ESMFold_hypothetical_protein	3gi8-assembly1.cif.gz_C	3gi8-assembly1.cif.gz_C Crystal Structure of ApcT K158A Transporter Bound to 7F11 Monoclonal Fab Fragment	9.947E+00	0.010	14	30	186	206	43	241	435	202	0.762	0.457
